JPH03167545A - Silver halide photographic sensitive material - Google Patents
Silver halide photographic sensitive materialInfo
- Publication number
- JPH03167545A JPH03167545A JP30736289A JP30736289A JPH03167545A JP H03167545 A JPH03167545 A JP H03167545A JP 30736289 A JP30736289 A JP 30736289A JP 30736289 A JP30736289 A JP 30736289A JP H03167545 A JPH03167545 A JP H03167545A
- Authority
- JP
- Japan
- Prior art keywords
- group
- silver halide
- silver
- emulsion
- grain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 107
- 239000004332 silver Substances 0.000 title claims abstract description 107
- -1 Silver halide Chemical class 0.000 title claims abstract description 104
- 239000000463 material Substances 0.000 title claims abstract description 38
- 239000000839 emulsion Substances 0.000 claims abstract description 92
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 91
- 229910052742 iron Inorganic materials 0.000 claims abstract description 45
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 38
- 125000003118 aryl group Chemical group 0.000 claims abstract description 25
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 21
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 15
- 150000002429 hydrazines Chemical class 0.000 claims abstract description 12
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 11
- 150000002505 iron Chemical class 0.000 claims abstract description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 25
- 238000011161 development Methods 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 239000003112 inhibitor Substances 0.000 claims description 12
- 239000000084 colloidal system Substances 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 5
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims 4
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims 1
- 235000020985 whole grains Nutrition 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 18
- 230000002829 reductive effect Effects 0.000 abstract description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 48
- 239000002245 particle Substances 0.000 description 43
- 238000000034 method Methods 0.000 description 40
- 239000010410 layer Substances 0.000 description 29
- 206010070834 Sensitisation Diseases 0.000 description 24
- 239000007864 aqueous solution Substances 0.000 description 24
- 230000008313 sensitization Effects 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 22
- 125000004432 carbon atom Chemical group C* 0.000 description 21
- 229920000159 gelatin Polymers 0.000 description 21
- 235000019322 gelatine Nutrition 0.000 description 21
- 108010010803 Gelatin Proteins 0.000 description 20
- 239000008273 gelatin Substances 0.000 description 20
- 235000011852 gelatine desserts Nutrition 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 19
- 239000000975 dye Substances 0.000 description 18
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 18
- AWDBHOZBRXWRKS-UHFFFAOYSA-N tetrapotassium;iron(6+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] AWDBHOZBRXWRKS-UHFFFAOYSA-N 0.000 description 17
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 15
- 229910021612 Silver iodide Inorganic materials 0.000 description 15
- 229940045105 silver iodide Drugs 0.000 description 15
- 239000003755 preservative agent Substances 0.000 description 14
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 14
- 125000001424 substituent group Chemical group 0.000 description 14
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 13
- 230000002335 preservative effect Effects 0.000 description 11
- 229910001961 silver nitrate Inorganic materials 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 150000004820 halides Chemical class 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 230000001235 sensitizing effect Effects 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 125000000565 sulfonamide group Chemical group 0.000 description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 5
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoric acid amide group Chemical group P(N)(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 4
- 125000001391 thioamide group Chemical group 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 235000010724 Wisteria floribunda Nutrition 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 3
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 125000006165 cyclic alkyl group Chemical group 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 239000006224 matting agent Substances 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 238000007142 ring opening reaction Methods 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 150000003464 sulfur compounds Chemical class 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 3
- 150000003585 thioureas Chemical class 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- 229910052724 xenon Inorganic materials 0.000 description 3
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical group C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 2
- DBCKMJVEAUXWJJ-UHFFFAOYSA-N 2,3-dichlorobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Cl)=C1Cl DBCKMJVEAUXWJJ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- OWIRCRREDNEXTA-UHFFFAOYSA-N 3-nitro-1h-indazole Chemical class C1=CC=C2C([N+](=O)[O-])=NNC2=C1 OWIRCRREDNEXTA-UHFFFAOYSA-N 0.000 description 2
- OCVLSHAVSIYKLI-UHFFFAOYSA-N 3h-1,3-thiazole-2-thione Chemical group SC1=NC=CS1 OCVLSHAVSIYKLI-UHFFFAOYSA-N 0.000 description 2
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010027146 Melanoderma Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000001555 benzenes Chemical group 0.000 description 2
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 150000002081 enamines Chemical group 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 159000000014 iron salts Chemical class 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000120 polyethyl acrylate Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 2
- 235000019252 potassium sulphite Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 150000003567 thiocyanates Chemical class 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 150000003852 triazoles Chemical group 0.000 description 2
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical compound SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- JAAIPIWKKXCNOC-UHFFFAOYSA-N 1h-tetrazol-1-ium-5-thiolate Chemical compound SC1=NN=NN1 JAAIPIWKKXCNOC-UHFFFAOYSA-N 0.000 description 1
- HAZJTCQWIDBCCE-UHFFFAOYSA-N 1h-triazine-6-thione Chemical compound SC1=CC=NN=N1 HAZJTCQWIDBCCE-UHFFFAOYSA-N 0.000 description 1
- XIWRQEFBSZWJTH-UHFFFAOYSA-N 2,3-dibromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1Br XIWRQEFBSZWJTH-UHFFFAOYSA-N 0.000 description 1
- GPASWZHHWPVSRG-UHFFFAOYSA-N 2,5-dimethylbenzene-1,4-diol Chemical compound CC1=CC(O)=C(C)C=C1O GPASWZHHWPVSRG-UHFFFAOYSA-N 0.000 description 1
- YKUDHBLDJYZZQS-UHFFFAOYSA-N 2,6-dichloro-1h-1,3,5-triazin-4-one Chemical compound OC1=NC(Cl)=NC(Cl)=N1 YKUDHBLDJYZZQS-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- AYPSHJCKSDNETA-UHFFFAOYSA-N 2-chloro-1h-benzimidazole Chemical compound C1=CC=C2NC(Cl)=NC2=C1 AYPSHJCKSDNETA-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical compound O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical class N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 description 1
- CLEJZSNZYFJMKD-UHFFFAOYSA-N 3h-1,3-oxazole-2-thione Chemical compound SC1=NC=CO1 CLEJZSNZYFJMKD-UHFFFAOYSA-N 0.000 description 1
- KWIVRAVCZJXOQC-UHFFFAOYSA-N 3h-oxathiazole Chemical compound N1SOC=C1 KWIVRAVCZJXOQC-UHFFFAOYSA-N 0.000 description 1
- NYYSPVRERVXMLJ-UHFFFAOYSA-N 4,4-difluorocyclohexan-1-one Chemical compound FC1(F)CCC(=O)CC1 NYYSPVRERVXMLJ-UHFFFAOYSA-N 0.000 description 1
- HDGMAACKJSBLMW-UHFFFAOYSA-N 4-amino-2-methylphenol Chemical compound CC1=CC(N)=CC=C1O HDGMAACKJSBLMW-UHFFFAOYSA-N 0.000 description 1
- UTMDJGPRCLQPBT-UHFFFAOYSA-N 4-nitro-1h-1,2,3-benzotriazole Chemical class [O-][N+](=O)C1=CC=CC2=NNN=C12 UTMDJGPRCLQPBT-UHFFFAOYSA-N 0.000 description 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 1
- GIQKIFWTIQDQMM-UHFFFAOYSA-N 5h-1,3-oxazole-2-thione Chemical compound S=C1OCC=N1 GIQKIFWTIQDQMM-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical class OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- NGDDCFINDCHPTF-UHFFFAOYSA-N [Br].[Ag] Chemical compound [Br].[Ag] NGDDCFINDCHPTF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 150000001661 cadmium Chemical class 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000005521 carbonamide group Chemical group 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- AJPXTSMULZANCB-UHFFFAOYSA-N chlorohydroquinone Chemical compound OC1=CC=C(O)C(Cl)=C1 AJPXTSMULZANCB-UHFFFAOYSA-N 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005262 decarbonization Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BBLSYMNDKUHQAG-UHFFFAOYSA-L dilithium;sulfite Chemical compound [Li+].[Li+].[O-]S([O-])=O BBLSYMNDKUHQAG-UHFFFAOYSA-L 0.000 description 1
- 150000002012 dioxanes Chemical class 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000002344 gold compounds Chemical class 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N hydroquinone methyl ether Natural products COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- AKCUHGBLDXXTOM-UHFFFAOYSA-N hydroxy-oxo-phenyl-sulfanylidene-$l^{6}-sulfane Chemical compound SS(=O)(=O)C1=CC=CC=C1 AKCUHGBLDXXTOM-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical group 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical class N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 125000002743 phosphorus functional group Chemical group 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- KIWUVOGUEXMXSV-UHFFFAOYSA-N rhodanine Chemical compound O=C1CSC(=S)N1 KIWUVOGUEXMXSV-UHFFFAOYSA-N 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 150000003475 thallium Chemical class 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- 125000005323 thioketone group Chemical group 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea group Chemical group NC(=S)N UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 229940062627 tribasic potassium phosphate Drugs 0.000 description 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は写真製版の分野で用いられる、超硬調な画像を
安定性の高い処理液をもって迅速に形成せしめるハロゲ
ン化銀写真感光材料(特にネガ型)に関するものである
。Detailed Description of the Invention (Field of Industrial Application) The present invention is applied to silver halide photographic materials (particularly negative materials) that are used in the field of photoengraving and are capable of rapidly forming ultra-high contrast images using a highly stable processing solution. (type).
(従来の技術)
写真製版の分野において網点画像による連続階調の画像
の再生あるいは線画像の再生を良好ならしめるために、
超硬調(特にガンマがlO以上)の写真特性を示す画像
形或システムが必要である。(Prior Art) In order to improve the reproduction of continuous tone images or line images using halftone images in the field of photoengraving,
There is a need for an image format or system that exhibits photographic characteristics of ultra-high contrast (especially gamma greater than 1O).
従来この目的のためにはリス現像液と呼ばれる特別な現
像液が用いられてきた。リス現像液は現像主薬としてハ
イドロキノンのみを含み、その伝染現像性を阻害しない
ように保恒剤たる亜硫酸塩をホルムアルデヒドとの付加
物の形にして用い遊離の亜硫酸イオンの濃度を極めて低
く(通常0.lモル/l以下)してある。そのためリス
現像液は極めて空気酸化を受けやすく3日を越える保存
に耐えられないという重大な欠点を持っている。Traditionally, a special developer called a Lith developer has been used for this purpose. Lith developer contains only hydroquinone as a developing agent, and uses sulfite as a preservative in the form of an adduct with formaldehyde so as not to inhibit its infectious development properties, and the concentration of free sulfite ions is kept extremely low (usually 0). .l mol/l or less). Therefore, the Lith developer has a serious drawback in that it is extremely susceptible to air oxidation and cannot be stored for more than 3 days.
高コントラストの写真特性を安定な現像液を用いて得る
方法としては米国特許第4, 224. 401号
、同第4,168,977号、同第4,166,742
号、同第4,311,781号、同第4,272,60
6号、同第4, 221. 857号、同第4,2
43,739号、同第4,269,929号等に記載さ
れているヒドラジン誘導体を用いる方法がある。この方
法によれば、超硬調で感度の高い写真特性が得られ、更
に現像液中に高感度の亜硫酸塩を加えることが許容され
るので、現像液の空気酸化に対する安定性はリス現像液
に比べて飛躍的に向上する。A method for obtaining high contrast photographic properties using a stable developer is described in U.S. Pat. No. 4,224. No. 401, No. 4,168,977, No. 4,166,742
No. 4,311,781, No. 4,272,60
No. 6, No. 4, 221. No. 857, No. 4, 2
There is a method using a hydrazine derivative described in No. 43,739, No. 4,269,929, etc. According to this method, photographic characteristics with ultra-high contrast and high sensitivity can be obtained, and since it is allowed to add a highly sensitive sulfite to the developer, the stability against air oxidation of the developer is better than that of the lithium developer. A dramatic improvement in comparison.
しかしながら、一般にハロゲン化銀写真感光材料におい
ては、単位現像銀量あたり得られる画像黒化濃度はハロ
ゲン化銀粒子のサイズが小さいほど高くなるが、ハロゲ
ン化銀の感度は一般にハロゲン化銀粒子のサイズが大き
いほど高くなる。したがって高い感度と高い黒化濃度を
与える感光材料を得ようと思えば、粒子サイズの大きな
ハロゲン化銀乳剤を単位面積あたり、より多く含有させ
ることが必要になる。ところが多量のハロゲン化銀乳剤
を含有させた感光材料は現像処理の段階で、定着、水洗
、乾燥に時間がかかる結果となり、迅速処理性をそこな
う結果となる。また銀は高価であり産出量も埋蔵量も限
られているため、できるだけ少ない銀を用いて感光材料
を生産することが求められている。However, in general, in silver halide photographic light-sensitive materials, the image blackening density obtained per unit amount of developed silver increases as the size of the silver halide grains decreases, but the sensitivity of silver halide generally increases due to the size of the silver halide grains. The larger the value, the higher the value. Therefore, in order to obtain a light-sensitive material that provides high sensitivity and high blackening density, it is necessary to contain a larger amount of silver halide emulsion having a larger grain size per unit area. However, a light-sensitive material containing a large amount of silver halide emulsion takes time to fix, wash, and dry during the development process, impairing rapid processing. Furthermore, since silver is expensive and has limited production and reserves, there is a need to produce photosensitive materials using as little silver as possible.
このようなことから、より少ない銀の使用で、高い画像
濃度と高い感度を有するハロゲン化銀感光材料の研究が
長年にわたってなされてきた。For this reason, research has been carried out for many years on silver halide photosensitive materials that have high image density and high sensitivity while using less silver.
一方、この新しい硬調ネガ画像システムはヒドラジン誘
導体の添加量によって、最大濃度を増加させようとする
と最大濃度が増加し著しい高感硬調化することができる
と同時に、伝染現像による黒ポヅ(black pep
per)という好ましくない現像をひきおこすことがあ
り、写真製版工程上の問題となっている。On the other hand, with this new high-contrast negative image system, if you try to increase the maximum density by changing the amount of hydrazine derivative added, it is possible to increase the maximum density and achieve a remarkable high-sensitivity contrast.
per), which is a problem in the photolithography process.
黒ポッというのは、本来未露光で非画像となるべき部分
に発生する微小な現像銀でできた黒いスポットである。A black spot is a black spot made of minute developed silver that occurs in an unexposed, non-image area.
黒ポツは、一般に保恒剤として現像液に使用されている
亜硫酸イオンの減少や、pH値の上昇により、多発し写
真製版用感材としての商品価値を著しく低下させてしま
う。従って、この黒ボツ改良のために多大な努力がなさ
れているが黒ポツの改良はしばしば感度及びガンマ(γ
)の低下をともない、高感硬調化を維持して黒ポツを改
良するシステムが強く望まれていた。このような方法の
一つとして、特開昭61〜77274号に粒子サイズ0
.5μ以下で、二種類の単分散乳剤とヒドラジン誘導体
を含むハロゲン化銀写真感光材料が開示されている。Black spots occur frequently due to a decrease in sulfite ions, which are generally used as a preservative in a developing solution, and an increase in pH value, significantly reducing the commercial value of the photolithographic material. Therefore, although great efforts are being made to improve these black spots, the improvement of black spots is often due to sensitivity and gamma (γ).
), there has been a strong desire for a system that maintains high contrast and improves black spots. As one such method, Japanese Patent Laid-Open No. 61-77274 describes particle size 0.
.. A silver halide photographic material containing two types of monodispersed emulsions and a hydrazine derivative with a particle size of 5 μm or less is disclosed.
又、写真製版の分野においては、印刷物の多用性、複雑
性に対処するために、オリジナル再現性の良好な写真感
光材料、安定な処理液あるいは、補充の簡易化などの要
望がある。Furthermore, in the field of photolithography, in order to deal with the versatility and complexity of printed matter, there are demands for photosensitive materials with good original reproducibility, stable processing solutions, and easy replenishment.
特に線画撮影工程における、原稿は写植文字、手書きの
文字、イラスト、網点化された写真などが貼り込まれて
作られる。したがって原稿には、濃度や、線巾の異なる
画像が混在し、これらの原稿を再現よく仕上げる製版カ
メラ、写真感光材料あるいは、画像形成方法が強く望ま
れている。Particularly in the line drawing process, manuscripts are created by pasting typesetting characters, handwritten characters, illustrations, halftone photographs, etc. Therefore, a document contains images of different densities and line widths, and there is a strong desire for a plate-making camera, a photosensitive material, or an image forming method that can finish these documents with good reproduction.
方、カタログや、大型ポスターの製版には、網写真の拡
大(目伸し)あるいは縮小(目縮め)が広く行なわれ、
網点を拡大して用いる製版では、線数が粗くなりボケた
点の撮影となる。縮小では原稿よりさらに線数/インチ
が大きく細い点の撮影になる。従って網階調の再現性を
維持するためより一層広いラチチュードを有する画像形
成方法が要求される。On the other hand, enlarging (stretching) or reducing (shrinking) net photographs is widely used in the making of catalogs and large posters.
In plate making that uses enlarged halftone dots, the number of lines becomes coarser, resulting in blurred dots. When reduced, the number of lines per inch is larger than that of the original, and a thinner point is photographed. Therefore, in order to maintain halftone reproducibility, an image forming method having a wider latitude is required.
製版用カメラの光源としては、ハロゲンランプあるいは
、キセノンランプが用いられている。これらの光源に対
して撮影感度を得るために、写真感光材料に通常オルソ
増感が施される。ところがオルソ増感した写真感光材料
はレンズの色収差の影響をより強く受け、そのために画
質が劣化しやすいことが判明した。またこの劣化はキセ
ノンランプ光源に対してより顕著となる。A halogen lamp or a xenon lamp is used as a light source for a plate-making camera. In order to obtain photographic sensitivity to these light sources, photographic materials are usually orthosensitized. However, it has been discovered that ortho-sensitized photographic materials are more strongly affected by the chromatic aberration of lenses, and as a result, image quality tends to deteriorate. Moreover, this deterioration is more noticeable for xenon lamp light sources.
上記画像システムはシャープな網点品質、処理安定性、
迅速性およびオリジナルの再現性という点で優れた性能
を示すが、近年の印刷物の多様性に対処するためにさら
にオリジナル再現性の改良されたシステムが望まれてい
る。The above image system has sharp halftone dot quality, processing stability,
Although it shows excellent performance in terms of speed and original reproducibility, a system with further improved original reproducibility is desired in order to cope with the diversity of printed matter in recent years.
粒子中の8族金属の分布に特徴があるハロゲン化銀粒子
とヒドラジン誘導体を併用した例は、ロジウムについて
は特開昭63−296031号に又イリジウムについて
は特願平1−128385号等に記載があるが、鉄につ
いての例はない。Examples of using silver halide grains characterized by the distribution of Group 8 metals in the grains in combination with hydrazine derivatives are described in JP-A-63-296031 for rhodium and in Japanese Patent Application No. 1-128385 for iridium. There is no example for iron.
又、鉄の分布に特徴があるハロゲン化銀粒子の例は特開
昭62−260137号、特開昭63−191145号
等に開示されているが、ヒドラジン誘導体と併用した例
はない。Further, examples of silver halide grains having a characteristic iron distribution are disclosed in JP-A-62-260137 and JP-A-63-191145, but there are no examples of their use in combination with hydrazine derivatives.
ヒドラジンを用いた系で、酸化されることにより現像抑
制剤を放出するレドックス化合物を含有する例は特開昭
61−213847号、同64一72140号に開示さ
れている。Examples of systems using hydrazine containing a redox compound that releases a development inhibitor upon oxidation are disclosed in JP-A-61-213847 and JP-A-64-72140.
(本発明が解決しようとする問題点)
本発明の第1の目的は、黒ポツが少なく高感度、高コン
トラスト(例えばγで10以上)で高い黒化濃度を得る
ことのできるハロゲン化銀写真感光材料及び画像形成方
法を提供することにある。(Problems to be Solved by the Present Invention) The first object of the present invention is to produce a silver halide photograph that can obtain high sensitivity, high contrast (for example, γ of 10 or more), and high blackening density with few black spots. The object of the present invention is to provide a photosensitive material and an image forming method.
本発明の第2の目的は、線画画質の優れた、γが10を
超える極めて高感で超硬調なハロゲン化銀写真感光材料
を提供することである。A second object of the present invention is to provide a silver halide photographic material with excellent line image quality and extremely high sensitivity and ultra-high contrast with γ exceeding 10.
(問題点を解決するための手段)
本発明の上記目的は、支持体上に少なくともl層のハロ
ゲン化銀乳剤層を有するハロゲン化銀写真感光材料にお
いて、該乳剤層が銀lモルあたり少なくとも1×10−
”モルの鉄塩を含有するハロゲン化銀乳剤からなり該ハ
ロゲン化銀乳剤の/%ロゲン化銀粒子が該粒子表面から
全粒子容積の50%に相当する部分に全粒子中の鉄含量
の60%以上の鉄を含んでいる粒子でありかつ該乳剤層
又はその他の親水性コロイド層中に下記一般式(I)で
表わされるヒドラジン誘導体をふくむことを特徴とする
ハロゲン化銀写真感光材料によって達成することができ
た。(Means for Solving the Problems) The above-mentioned object of the present invention is to provide a silver halide photographic material having at least one silver halide emulsion layer on a support, in which the emulsion layer has at least one silver halide emulsion layer per mole of silver. ×10-
% silver halide grains of the silver halide emulsion contain 60% of the iron content in the total grains from the grain surface to a portion corresponding to 50% of the total grain volume. Achieved by a silver halide photographic light-sensitive material, which is characterized in that it is grains containing iron in an amount of % or more, and contains a hydrazine derivative represented by the following general formula (I) in the emulsion layer or other hydrophilic colloid layer. We were able to.
一般式(I)
R.−N−N−G,−R2
【
AIAI
式中、R1は脂肪族基または芳香族基またはへテロ環基
を表わし、R2は水素原子、アルキル基、アリール基、
アルコキシ基、アリールオキシ基、アミノ基、カルバモ
イル基又はオキシカルボニル基を表わし、Glはカルボ
ニル基、スルホニル基、ルポニル基、又はイミノメチレ
ン基を表わし、A. 、Atはともに水素原子あるいは
一方が水素原子で他方が置換もしくは無置換のアルキル
スルホニル基、又は置換もしくは無置換のアリールスル
ホニル基、又は置換もしくは無置換のアシル基を表わす
。General formula (I) R. -N-N-G, -R2 [AIAI] In the formula, R1 represents an aliphatic group, an aromatic group, or a heterocyclic group, and R2 is a hydrogen atom, an alkyl group, an aryl group,
A. , At both represent a hydrogen atom, one hydrogen atom and the other a substituted or unsubstituted alkylsulfonyl group, a substituted or unsubstituted arylsulfonyl group, or a substituted or unsubstituted acyl group.
本発明の第2の目的は、乳剤層またはその他の親水性コ
ロイド層に酸化されることにより現像抑制剤を放出する
レドックス化合物を含有することを特徴とする前記ネガ
型ハロゲン化銀写真感光材料によってさらに良化した。A second object of the present invention is to provide the negative-working silver halide photographic light-sensitive material characterized in that the emulsion layer or other hydrophilic colloid layer contains a redox compound that releases a development inhibitor upon oxidation. It got even better.
以下に本発明のハロゲン化銀粒子について詳しく説明す
る。The silver halide grains of the present invention will be explained in detail below.
本発明に於ではハロゲン化銀粒子中の鉄の分布に特徴が
ある。即ち、粒子の全容積の内、粒子表面から粒子容積
の50%に相当する部分までの部分に、全粒子中の鉄総
含量の60%以上、好ましくは80%以上が存在するこ
とにある。The present invention is characterized by the distribution of iron in the silver halide grains. That is, 60% or more, preferably 80% or more of the total iron content in all particles is present in the area from the particle surface to a portion corresponding to 50% of the particle volume within the total volume of the particles.
即ち、粒子内部よりも粒子表面に近い部分に多量の鉄が
存在することが特徴である。That is, it is characterized by the presence of a larger amount of iron in a portion closer to the particle surface than in the interior of the particle.
特に粒子表面から全粒子容積の30%に相当する部分に
全粒子中の鉄総含量の60%以上が存在することが好ま
しい。とくに粒子表面部分に局在することが好ましい。In particular, it is preferable that 60% or more of the total iron content in all particles is present in a portion corresponding to 30% of the total particle volume from the particle surface. In particular, it is preferable that the particles be localized on the surface of the particles.
本発明のハロゲン化銀粒子は、鉄含有率について、二重
構造以上の多重構造でもいいし、含有率が連続的に変化
する構造でもいいが、二重構造であることが好ましい。Regarding the iron content, the silver halide grains of the present invention may have a multiple structure with a double structure or more, or a structure in which the iron content changes continuously, but a double structure is preferable.
二重構造である場合には、より粒子中心に近い層である
内芯部の鉄含有率がより粒子表面に近い層である外殻部
のそれより少なく、又外殻部に局在していることが好ま
しい。In the case of a double structure, the iron content in the inner core, which is the layer closer to the center of the particle, is lower than that in the outer shell, which is the layer closer to the particle surface, and the iron content is localized in the outer shell. Preferably.
又、多重構造である場合は、最も粒子表面に近い層の鉄
含有率が最も高いことが好ましく連続的に変化する構造
である場合は、全粒子容積のうち、粒子表面に近い部分
20%の容積中に、鉄含有率が最も高い部分のあること
が好ましい。In addition, in the case of a multilayer structure, it is preferable that the layer closest to the particle surface has the highest iron content, and in the case of a structure that changes continuously, the iron content of the layer closest to the particle surface is 20% of the total particle volume. Preferably, there is a portion of the volume with the highest iron content.
本発明におけるホスト結晶の平均粒子サイズは0.7μ
m以下が好ましく、より好ましくは0.2μm〜0.5
μmである。粒子サイズ分布は、単分散が好ましい。The average particle size of the host crystal in the present invention is 0.7μ
m or less is preferable, more preferably 0.2 μm to 0.5
It is μm. The particle size distribution is preferably monodisperse.
ここでいう単分散粒子とは、下記で定義される変動係数
が20%以下、特に好ましくは15%以下である粒子サ
イズ分布を有するハロゲン化銀乳剤を意味する。Monodisperse grains herein mean a silver halide emulsion having a grain size distribution with a coefficient of variation defined below of 20% or less, particularly preferably 15% or less.
ハロゲン化銀が二重構造である場合は、本発明の鉄含有
率の少ない芯部を構成するハロゲン化銀の平均粒径は、
0.03〜0.45μ、好ましくは0.1〜0.35μ
であって、平均粒径から粒径の偏差が±40%以内、好
ましくは±20%より少ない分布の狭い粒子が好ましい
。When the silver halide has a double structure, the average grain size of the silver halide constituting the core with low iron content of the present invention is
0.03-0.45μ, preferably 0.1-0.35μ
Preferably, the particles have a narrow distribution, and the deviation of the particle size from the average particle size is within ±40%, preferably less than ±20%.
本発明の鉄含有率の高い外殻部が芯部上に積層した後の
最終平均粒径は0.5μ以下が好ましく、より好ましく
は0.2μ〜0.4μである。The final average particle diameter after the outer shell portion with a high iron content of the present invention is laminated on the core portion is preferably 0.5μ or less, more preferably 0.2μ to 0.4μ.
ハロゲン化銀内の鉄分布は、適当な濃度量の(NH4L
StC)+溶液を数回に分けて逐次エッチングを行ない
各液中の銀量、鉄量の定量を行ない粒子体積に換算する
ことによって求めることができる。定量は原子吸光法等
によって行なうことができる。The distribution of iron in silver halide is determined by the concentration of (NH4L
It can be determined by sequentially etching the StC)+ solution several times, quantifying the amounts of silver and iron in each solution, and converting them into particle volumes. Quantification can be performed by atomic absorption method or the like.
ハロゲン化銀が二重構造である場合は内芯部の鉄含有率
としてはO〜5X10−’モル/モル銀、外殻部の鉄含
有率は1.OXIO−’〜5.OX10−4モル/モル
銀であることが好ましい。When the silver halide has a double structure, the iron content in the inner core is 0 to 5 x 10-' mol/mole silver, and the iron content in the outer shell is 1. OXIO-'~5. Preferably it is OX10-4 mole/mole silver.
鉄含有率の少ない芯部と多い殻部の構成は容積比で1+
100〜100 : 1の間で任意に選択できるが1:
10〜10:1の範囲であることが好ましい。The structure of the core with low iron content and the shell with high iron content has a volume ratio of 1+
Can be arbitrarily selected between 100 and 100:1, but 1:
Preferably, the ratio is in the range of 10 to 10:1.
鉄原子を粒子中に含有せしめるには、ハロゲン化銀乳剤
の製造工程の物理熟成終了前とくに粒子形戊時に鉄塩を
加えることが望ましい。In order to incorporate iron atoms into the grains, it is desirable to add iron salts before completing physical ripening in the silver halide emulsion manufacturing process, especially when forming the grains.
ここで用いられる鉄塩は、水溶性の鉄塩または鉄錯塩で
、例えば硫酸鉄(II) F e S 0,5 8gO
;塩化鉄(III)FeC1.;ヘキサシアノ鉄(II
)酸カリウムK+F e (CN)s ’ 3 H20
;ヘキサシアノ鉄(III)酸カリウムK h F
e (C N )sなどである。The iron salt used here is a water-soluble iron salt or iron complex salt, for example, iron sulfate (II) Fe S 0,5 8gO
; iron(III) chloride FeC1. ; Hexacyanoiron (II
) acid potassium K+F e (CN)s' 3 H20
; Potassium hexacyanoferrate (III) K h F
e(CN)s, etc.
これらの水溶性鉄塩の添加量は、ハロゲン化銀lモル当
たり1.OX10−’モル以上であり、好ましくは1×
10−’〜5X10−”モルの範囲である。The amount of these water-soluble iron salts added is 1.5 g/mol of silver halide. OX10-' mole or more, preferably 1×
It ranges from 10-' to 5X10-' moles.
上記水溶性鉄塩を用いてハロゲン化銀粒子形成時に存在
させるには水溶性銀塩と水溶性ハライド溶液を同時混合
するとき、水溶性銀塩中またはハライド溶液中に添加し
ておく方法が好ましい。あるいは銀塩とハライド溶液が
同時に混合されるとき第3の溶液として、3液同時混合
の方法でハロゲン化銀粒子を調製してもよい。又、粒子
形成中もしくは直後または物理熟成時途中もしくは終了
時に必要量の鉄塩の水溶液を反応容器に投入してもよい
。In order to make the water-soluble iron salt present during the formation of silver halide grains, it is preferable to add it to the water-soluble silver salt or halide solution when simultaneously mixing the water-soluble silver salt and the water-soluble halide solution. . Alternatively, when silver salt and halide solutions are mixed simultaneously, silver halide grains may be prepared by a method of simultaneous mixing of three solutions as a third solution. Further, a required amount of an aqueous solution of iron salt may be introduced into the reaction vessel during or immediately after particle formation, or during or at the end of physical ripening.
なお、総塗布銀量としては、1 g/n{〜8g/dが
好ましい。The total amount of silver coated is preferably 1 g/n to 8 g/d.
写真乳剤中のハロゲン化銀粒子は立方体、八面体のよう
な規則的(regular)な結晶体を有するものでも
よく、また球状、板状などのような変則的( irre
gu far)な結晶を持つもの、あるいはこれらの結
晶形の複合形を持つものであってもよい。The silver halide grains in the photographic emulsion may have a regular crystal structure such as a cube or an octahedron, or may have an irregular crystal structure such as a spherical shape or a plate shape.
gu far) crystals, or a composite form of these crystal forms.
本発明に用いられるハロゲン化銀乳剤は塩化銀、塩臭化
銀、沃臭化銀、沃塩臭化銀等どの組成でもかまわないが
、70モル%以上、とくに90モル%以上が臭素銀から
なるハロゲン化銀が好ましい。The silver halide emulsion used in the present invention may have any composition such as silver chloride, silver chlorobromide, silver iodobromide, silver iodochlorobromide, etc., but 70 mol% or more, especially 90 mol% or more of silver bromine. Silver halides are preferred.
沃化銀の含量は10モル%以下、特に0. 1〜5モ
ル%であることが好ましい。The content of silver iodide is 10 mol% or less, especially 0. It is preferably 1 to 5 mol%.
本発明に用いられるハロゲン化銀粒子は P.Glaf
kides著Chimie et Physique
Photographiqu(Paul Monte1
社刊、1967年) 、G.F.Duffin著Pho
tographic Emulsion Che+ni
stry (The FocalPress刊、l96
6年) 、V.L.Zelikman et al著M
aking and Coating Photogr
aphic Emulsion (TheFocal
Press刊、1964年)などに記載されたZ法を用
いて調製することができる。The silver halide grains used in the present invention are P. Glaf
Chimie et Physique by kids
Photography (Paul Monte1)
Publishing, 1967), G. F. Pho by Duffin
tographic Emulsion Che+ni
stry (The Focal Press, l96
6 years), V. L. Written by Zelikman et al.
making and coating photogr
aphic Emulsion (The Focal
Press, 1964).
即ち、酸性法、中性法、アンモニア法等のいずれでもよ
く、又可溶性銀塩と可溶性ハロゲン塩を反応させる形成
としては、片側混合法、同時混合法、それらの組合せな
どのいずれを用いてもよい。That is, any of the acidic method, neutral method, ammonia method, etc. may be used, and the formation of the reaction between the soluble silver salt and the soluble halogen salt may be performed using any of the one-sided mixing method, simultaneous mixing method, and a combination thereof. good.
粒子を銀イオン過剰の下において形或させる方法(いわ
ゆる逆混合法)を用いることもできる。It is also possible to use a method in which particles are formed under an excess of silver ions (so-called back-mixing method).
同時混合法の一つの形式としてハロゲン化銀の生成され
る液相中のpAgを一定に保つ方法、即ち、いわゆるコ
ントロールド、ダブルジェット法を用いることもできる
。As one type of simultaneous mixing method, a method in which the pAg in the liquid phase in which silver halide is produced can be kept constant, that is, a so-called controlled double jet method can also be used.
この方法によると、結晶形が規則的で粒子サイズが均一
に近いハロゲン化銀乳剤が得られる。According to this method, a silver halide emulsion having a regular crystal shape and a nearly uniform grain size can be obtained.
また、粒子サイズを均一にするためには、英国特許1,
535, 016号、特公昭4 8−3 6 8
90、同52−16364号に記載されているように、
硝酸銀やハロゲン化アルカリの添加速度を粒子成長速度
に応じて変化させる方法や、英国特許4,242,44
5号、特開昭55−158124号に記載されているよ
うに水溶液の濃度を変化させる方法を用いて、臨界飽和
度を超えない範囲において早く成長させることが好まし
い。In addition, in order to make the particle size uniform, British patent 1,
No. 535, 016, Special Publication No. 4 8-3 6 8
90, No. 52-16364,
A method of changing the addition rate of silver nitrate or alkali halide depending on the particle growth rate, and British Patent No. 4,242,44
It is preferable to use a method of changing the concentration of an aqueous solution as described in No. 5, JP-A No. 55-158124, to grow rapidly within a range that does not exceed the critical saturation level.
本発明に用いられるハロゲン化銀溶剤としては、米国特
許第3,271,157号、同第3,531,289号
、同第3.574,628号等に記載された (a)有
機チオエーテル類、特開昭53−82408号、同5
5−7 7 7 3 7号に記載された (b)チオ尿
素誘導体、特開昭53−144319号に記載された
(Cl酸素またはカルボニル基を有するハロゲン化銀溶
剤、特開昭54−100717号に記載された (d)
イミダゾール類 (e)亜硫酸塩 (f)チオシアネー
ト類が挙げられる。中でも特に好ましいのはチオエーテ
ル類である。As the silver halide solvent used in the present invention, (a) organic thioethers described in U.S. Pat. No. 3,271,157, U.S. Pat. , Japanese Patent Publication No. 53-82408, 5
(b) Thiourea derivatives described in JP-A-53-144319
(Silver halide solvent having Cl oxygen or carbonyl group, described in JP-A-54-100717 (d)
Examples include imidazoles (e) sulfites (f) thiocyanates. Among these, thioethers are particularly preferred.
以下にこの具体的化合物を示す。Specific compounds are shown below.
CH.−NHCOCH2CH2COH
C H t S C H 2 C H 2 S C
t H sf{O−(CH*)*−S−(CH!)t
−S−(C}It)t−OH本発明に用いるに適したハ
ロゲン化銀は、粒子表面の沃化銀含有率が粒子平均の沃
化銀含有率よりも大きいハロ沃化銀である。かかるハロ
沃化銀を含む乳剤を用いるとより一層高感度でガンマの
高い写真特性が得られる。CH. -NHCOCH2CH2COH C H t S C H 2 C H 2 S C
t H sf{O-(CH*)*-S-(CH!)t
-S-(C}It)t-OH The silver halide suitable for use in the present invention is a silver halide iodide in which the silver iodide content on the grain surface is larger than the silver iodide content on the grain average. When an emulsion containing such silver haloiodide is used, photographic characteristics with higher sensitivity and higher gamma can be obtained.
本発明に用いるハロゲン化銀乳剤にはハロゲン化銀粒子
の形成または物理熟戊の過程においてカドミウム塩、亜
硫酸塩、鉛塩、タリウム塩、ロジウム塩もしくはその錯
塩、イリジウム塩もしくはその錯塩などを共存させても
よい。In the silver halide emulsion used in the present invention, cadmium salt, sulfite, lead salt, thallium salt, rhodium salt or its complex salt, iridium salt or its complex salt, etc. are allowed to coexist in the silver halide grain formation or physical ripening process. You can.
本発明の乳剤は、化学増感されていなくてもよいが化学
増感されていてもよい。化学増感の方法としては、硫黄
増感、還元増感、金増感等の知られている方法を用いる
ことができ、単独または組合せで用いられる。好ましい
化学増感方法は硫黄増感である。The emulsion of the present invention may not be chemically sensitized, but may be chemically sensitized. As a chemical sensitization method, known methods such as sulfur sensitization, reduction sensitization, gold sensitization, etc. can be used, and these methods are used alone or in combination. A preferred chemical sensitization method is sulfur sensitization.
硫黄増加剤としては、ゼラチン中に含まれる硫黄化合物
のほか、種々の硫黄化合物、たとえばチオ硫酸塩、チオ
尿素類、チアゾール類、ローダニン類等を用いることが
できる。具体例は米国特許1,574,944号、同2
,278.947号、同2,410,689号、同2,
728,668号、同3,501.313号、同3,
656, 955号に記載されたものである。好まし
い硫黄化合物は、チオ硫酸塩、チオ尿素化合物であり、
化学増感時のpAgとしては好ましくは8.3以下、よ
り好ましくは、7.3〜8.0の範囲である。As the sulfur increaser, in addition to the sulfur compounds contained in gelatin, various sulfur compounds such as thiosulfates, thioureas, thiazoles, rhodanines, etc. can be used. Specific examples are U.S. Patent Nos. 1,574,944 and 2.
, No. 278.947, No. 2,410,689, No. 2,
No. 728,668, No. 3,501.313, No. 3,
No. 656,955. Preferred sulfur compounds are thiosulfates and thiourea compounds,
The pAg during chemical sensitization is preferably 8.3 or less, more preferably in the range of 7.3 to 8.0.
さらにMoisar, Klein Gelatine
. Proc. Symp. 2nd,301〜309
(1970)らによって報告されているようなポリビ
ニルピロリドンとチオ硫酸塩を併用する方法も良好な結
果を与える。Furthermore, Moisar, Klein Gelatine
.. Proc. Symp. 2nd, 301-309
(1970) et al. also give good results using a combination of polyvinylpyrrolidone and thiosulfate.
貴金属増感法のうち金増感法はその代表的なもので金化
合物、主として金錯塩を用いる。金以外の貴金属、たと
えば白金、パラジウム、イリジウム等の錯塩を含有して
も差支えない。その具体例は米国特許2,448,06
0号、英国特許6l8,061号などに記載されている
。Among the noble metal sensitization methods, the gold sensitization method is a typical method and uses a gold compound, mainly a gold complex salt. There is no problem in containing complex salts of noble metals other than gold, such as platinum, palladium, and iridium. A specific example is U.S. Patent No. 2,448,06
No. 0, British Patent No. 6l8,061, etc.
還元増感剤としては第一すず塩、アミン類、ホルムアミ
ジンスルフィン酸、シラン化合物などを用いることがで
き、それらの具体例は米国特許2,487,850号、
2,518,698号、2,983,609号、2,9
83.610号、2,694,637号に記載されてい
る。As the reduction sensitizer, stannous salts, amines, formamidine sulfinic acid, silane compounds, etc. can be used, and specific examples thereof include U.S. Pat. No. 2,487,850,
No. 2,518,698, No. 2,983,609, 2,9
No. 83.610 and No. 2,694,637.
本発明に用いられる感光材料中のハロゲン化銀乳剤は、
一種だけでもよいし、二種以上(例えば、平均粒子サイ
ズの異なるもの、ハロゲン組成の異なるもの、晶癖の異
なるもの、化学増感の条件の異なるもの)併用してもよ
い。The silver halide emulsion in the light-sensitive material used in the present invention is
One type may be used alone, or two or more types (for example, those with different average particle sizes, those with different halogen compositions, those with different crystal habits, and those with different chemical sensitization conditions) may be used in combination.
本発明においてハロゲン化銀乳剤層は特開昭61−22
3734号、同6 2−9 0 6 4 6号に開示さ
れているような平均粒子サイズの異なる2種類の単分散
乳剤を含むことが最高濃度( Dmax)上昇という点
で好ましく、小サイズ単分散粒子は化学増感されている
ことが好ましく、化学増感の方法は硫黄増感が最も好ま
しい。大サイズ単分散乳剤の化学増感はされていなくて
もよいが、化学増感されていてもよい。大サイズ単分散
粒子は一般に黒ポッが発生しやすいので化学増感を行な
わないか、化学増感するときは黒ポッが発生しない程度
に浅く施すことが特に好ましい。ここで「浅く施す」と
は小サイズ粒子の化学増感に較べ化学増感を施す時間を
短くしたり、温度を低くしたり化学増感剤の添加量を抑
えたりして行なうことである。大サイズ単分散乳剤と小
サイズ単分散乳剤の感度差には特に制限はないが△j7
ogEとして0.1〜l. O、より好まし<0.2
〜0.7であり、大サイズ単分散乳剤が高い方が好まし
い。In the present invention, the silver halide emulsion layer is
It is preferable to include two types of monodisperse emulsions with different average grain sizes as disclosed in No. 3734 and No. 62-90646, from the viewpoint of increasing the maximum density (Dmax), and The particles are preferably chemically sensitized, and the most preferred chemical sensitization method is sulfur sensitization. The large size monodisperse emulsion does not need to be chemically sensitized, but it may be chemically sensitized. Since large-sized monodisperse particles generally tend to generate black spots, it is particularly preferable that chemical sensitization is not performed, or when chemical sensitization is applied, the chemical sensitization is applied shallowly to the extent that black spots do not occur. Here, "shallow application" means that chemical sensitization is performed by shortening the time, lowering the temperature, or suppressing the amount of chemical sensitizer added compared to chemical sensitization of small-sized particles. There is no particular limit to the sensitivity difference between large-sized monodispersed emulsions and small-sized monodispersed emulsions, but △j7
ogE is 0.1-l. O, more preferably <0.2
~0.7, and the higher the value is, the more preferable it is for large-sized monodispersed emulsions.
ここで、各乳剤の感度はヒドラジン誘導体を含有させ支
持体上に塗布し、亜硫酸イオンを01.5モル/l以上
含むpH10.5〜12.3の現像液を用いて処理した
ときに得られるものである。Here, the sensitivity of each emulsion is obtained when it is coated on a support containing a hydrazine derivative and processed using a developer with a pH of 10.5 to 12.3 containing 01.5 mol/l or more of sulfite ions. It is something.
より具体的には実施例1に記載された評価方法に準じる
。More specifically, the evaluation method described in Example 1 was followed.
小サイズ単分散粒子の平均粒子サイズは、大サイズのハ
ロゲン化銀単分散粒子の平均サイズの90%以下であり
、好ましくは80%以下である。The average grain size of the small monodisperse grains is 90% or less, preferably 80% or less, of the average grain size of the large monodisperse silver halide grains.
ハロゲン化銀乳剤粒子の平均粒子サイズは、好ましくは
0.02μ〜1. 0μより好ましくは0.1μ〜0
. 5μでこの範囲内に大サイズと小サイズ単分散粒
子の平均粒子サイズが含まれていることが好ましい。The average grain size of the silver halide emulsion grains is preferably 0.02μ to 1.0μ. More preferably 0.1μ to 0
.. It is preferable that the average particle size of the large-sized and small-sized monodisperse particles is 5μ and included within this range.
本発明においてサイズの異なった2種以上の乳剤を用い
るとき小サイズ単分散乳剤の塗布銀量としては、総塗布
銀量に対して、好ましくは40〜90wt%、より好ま
しくは50〜80Wt%である。In the present invention, when two or more emulsions of different sizes are used, the coating silver amount of the small-sized monodisperse emulsion is preferably 40 to 90 wt%, more preferably 50 to 80 wt%, based on the total coating silver amount. be.
本発明において粒子サイズの異なる単分散乳剤を導入す
る方法としては、同一乳剤に導入してもよく、あるいは
別々の層に導入してもかまわない。In the present invention, monodispersed emulsions having different grain sizes may be introduced into the same emulsion or may be introduced into separate layers.
別々の層に導入するときは、大サイズ乳剤を上層に、小
サイズ乳剤を下層にするのが好ましい。When introduced in separate layers, it is preferred that the large emulsion be in the upper layer and the small emulsion in the lower layer.
本発明に用いられるヒドラジン誘導体は、下記一般式(
I)によって表わされる化合物が好ましい。The hydrazine derivative used in the present invention has the following general formula (
Preference is given to compounds represented by I).
一般式(I)
式中、R1は脂肪族基または芳香族基またはへテロ環を
表わし、R2は水素原子、アルキル基、アリール基、ア
ルコキシ基、アリールオキシ基、アミノ基、カルバモイ
ル基、オキシカルポニル基、O
11
またはヒドラジノ基を表わし、G1は一〇一基、一基、
チオカルボニル基又はイミノメチレン基を表わし、A1
、A2はともに水素原子あるいは一方が水素原子で他方
が置換もしくは無置換のアルキルスルホニル基、又は置
換もしくは無置換のアリールスルホニル基、又は置換も
しくは無置換のアシル基を表わす。General formula (I) In the formula, R1 represents an aliphatic group, an aromatic group, or a heterocycle, and R2 is a hydrogen atom, an alkyl group, an aryl group, an alkoxy group, an aryloxy group, an amino group, a carbamoyl group, or an oxycarponyl group. group, O 11 or hydrazino group, G1 is 101 groups, 1 group,
Represents a thiocarbonyl group or iminomethylene group, A1
, A2 both represent a hydrogen atom, one a hydrogen atom and the other a substituted or unsubstituted alkylsulfonyl group, a substituted or unsubstituted arylsulfonyl group, or a substituted or unsubstituted acyl group.
一般式CI)において、R1で表される脂肪族基は好ま
しくは炭素数1〜30のものであって、特に炭素数1〜
20の直鎖、分岐または環状のアルキル基である。この
アルキル基は置換基を有していてもよい。In general formula CI), the aliphatic group represented by R1 preferably has 1 to 30 carbon atoms, particularly 1 to 30 carbon atoms.
20 straight chain, branched or cyclic alkyl groups. This alkyl group may have a substituent.
一般式(I)においてR.で表される芳香族基は単環ま
たは2環のアリール基または不飽和へテロ環基である。In general formula (I), R. The aromatic group represented by is a monocyclic or bicyclic aryl group or an unsaturated heterocyclic group.
ここで不飽和へテロ環基はアリール基と縮環していても
よい。Here, the unsaturated heterocyclic group may be fused with an aryl group.
R.として好ましいものはアリール基であり、特に好ま
しくはベンゼン環を含むものである。R. Preferred is an aryl group, particularly preferred is one containing a benzene ring.
R1の脂肪族基または芳香族基は置換されていてもよく
、代表的な置換基としては例えばアルキル基、アラルキ
ル基、アルケニル基、アルキニル基、アルコキシ基、ア
リール基、置換アミノ基、ウレイド基、ウレタン基、ア
リールオキシ基、スルファモイル基、カルバモイル基、
アルキルまたはアリールチオ基、アルキルまたはアリー
ルスルホニル基、アルキルまたはアリールスルフィニル
基、ヒドロキシ基、ハロゲン原子、シアノ基、スルホ基
、アリールオキシカルボニル基、アシル基、アルコキシ
カルボニル基、アシルオキシ基、カルボンアミド基、ス
ルホンアミド基、カルボキシル基、リン酸アミド基、ジ
アシルアミノ基、イミドR2
ましい置換基としてはアルキル基(好ましくは炭素数l
〜20のもの)、アラルキル基(好ましくは炭素数7〜
30のもの)、アルコキシ基(好ましくは炭素数1〜2
0のもの)、置換アミノ基(好ましくは炭素数1〜20
のアルキル基で置換されたアミノ基)、アシルアミノ基
(好ましくは炭素数2〜30を持つもの)、スルホンア
ミド基(好ましくは炭素数1〜30を持つもの)、ウレ
イド基(好ましくは炭素数1〜30を持つもの)、リン
酸アミド基(好ましくは炭素数1〜30のもの)などで
ある。The aliphatic group or aromatic group of R1 may be substituted, and typical substituents include an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an aryl group, a substituted amino group, a ureido group, Urethane group, aryloxy group, sulfamoyl group, carbamoyl group,
Alkyl or arylthio group, alkyl or arylsulfonyl group, alkyl or arylsulfinyl group, hydroxy group, halogen atom, cyano group, sulfo group, aryloxycarbonyl group, acyl group, alkoxycarbonyl group, acyloxy group, carbonamide group, sulfonamide group, carboxyl group, phosphoric acid amide group, diacylamino group, imide R2 Preferred substituents are alkyl groups (preferably carbon atoms
~20 carbon atoms), aralkyl groups (preferably 7~20 carbon atoms),
30), alkoxy group (preferably 1 to 2 carbon atoms)
0), substituted amino groups (preferably 1 to 20 carbon atoms), substituted amino groups (preferably 1-20 carbon atoms)
(an amino group substituted with an alkyl group), an acylamino group (preferably one having 2 to 30 carbon atoms), a sulfonamide group (preferably one having 1 to 30 carbon atoms), a ureido group (preferably one having 1 carbon number) 30), a phosphoric acid amide group (preferably one having 1 to 30 carbon atoms), and the like.
一般式(I)においてR.で表わされるアルキル基とし
ては、好ましくは炭素数1〜4のアルキル基であり、ア
リール基としては単環または2環のアリール基が好まし
い(例えばベンゼン環を含むもの)。In general formula (I), R. The alkyl group represented by is preferably an alkyl group having 1 to 4 carbon atoms, and the aryl group is preferably a monocyclic or bicyclic aryl group (for example, one containing a benzene ring).
O
11
G,がーC一基の場合、R2で表わされる基のうち好ま
しいものは、水素原子、アルキル基(例えば、メチル基
、トリフルオロメチル基、3−ヒドロキシプロビル基、
3−メタンスルホンアミドプロビル基、フェニルスルホ
ニルメチル基など)、アラルキル基(例えば、0−ヒド
ロキシベンジル基など)、アリール基(例えば、フエニ
ル基、3,5−ジクロロフェニル基、0−メタンスルホ
ンアミドフエニル基、4−メタンスルホニルフエニル基
、2−ヒドロキシメチルフエニル基など)などであり、
特に水素原子が好ましい。When O 11 G, -C is one group, preferred among the groups represented by R2 are a hydrogen atom, an alkyl group (for example, a methyl group, a trifluoromethyl group, a 3-hydroxyprobyl group,
3-methanesulfonamidoprobyl group, phenylsulfonylmethyl group, etc.), aralkyl group (e.g., 0-hydroxybenzyl group, etc.), aryl group (e.g., phenyl group, 3,5-dichlorophenyl group, 0-methanesulfonamidopropyl group, etc.), enyl group, 4-methanesulfonylphenyl group, 2-hydroxymethylphenyl group, etc.),
Particularly preferred is a hydrogen atom.
R2は置換されていても良く、置換基としては、R.に
関して列挙した置換基が適用できる。R2 may be substituted, and examples of the substituent include R. The substituents listed for are applicable.
O 11 一般式(I)のGとしてはーC一基が最も好ましい。O 11 G in general formula (I) is most preferably -C group.
又、R2はG.−R2の部分を残余分子から分裂させ、
−G,−R.部分の原子を含む環式構造を生成させる環
化反応を生起するようなものであってもよく、その例と
しては例えば特開昭6329751号などに記載のもの
が挙げられる。Also, R2 is G. - Splitting the R2 part from the remaining molecule,
-G, -R. It may be one that causes a cyclization reaction to produce a cyclic structure containing atoms of the moiety, and examples thereof include those described in JP-A-6329751.
A. 、A2としては水素原子が最も好ましい。A. , A2 is most preferably a hydrogen atom.
一般式(I)のRlまたはR2はその中にカプラー等の
不動性写真用添加剤において常用されているバラスト基
またはポリマーが組み込まれているものでもよい。バラ
スト基は8以上の炭素数を有する写真性に対して比較的
不活性な基であり、例えばアルキル基、アルコキシ基、
フェニル基、アルキルフエニル基、フェノキシ基、アル
キルフェノキシ基などの中から選ぶことができる。また
ポリマーとしては例えば特開平1−100530号に記
載のものが挙げられる。R1 or R2 in the general formula (I) may have a ballast group or a polymer commonly used in immobile photographic additives such as couplers incorporated therein. A ballast group is a group having 8 or more carbon atoms and is relatively inert to photography, such as an alkyl group, an alkoxy group,
It can be selected from phenyl group, alkylphenyl group, phenoxy group, alkylphenoxy group, etc. Examples of the polymer include those described in JP-A-1-100530.
一般式(I)のR1またはR2はその中にハロゲン化銀
粒子表面に対する吸着を強める基が組み込まれているも
のでもよい。かかる吸着基としては、チオ尿素基、複素
環チオアミド基、メルカプト複素環基、トリアゾール基
などの米国特許第4,385,108号、同4,459
,347号、特開昭59−195,233号、同59−
200,231号、同59−201,045号、同59
−201.046号、同59−201.047号、同5
9−201,048号、同59−201,049号、特
開昭61−170,733号、同6l270,744号
、同6 2−9 4 8号、特願昭62−67,508
号、同62−67,501号、同62−67,510号
に記載された基があげられる。R1 or R2 in general formula (I) may have a group incorporated therein to enhance adsorption to the silver halide grain surface. Such adsorption groups include thiourea groups, heterocyclic thioamide groups, mercapto heterocyclic groups, triazole groups, etc.
, No. 347, JP-A No. 59-195, 233, No. 59-
No. 200,231, No. 59-201,045, No. 59
-201.046, 59-201.047, 5
9-201,048, 59-201,049, JP-A-61-170,733, JP-A-61270,744, JP-A-62-9-4-8, JP-A-62-67,508
No. 62-67,501 and No. 62-67,510.
一般式(I)で示される化合物の具体例を以下に示す。Specific examples of the compound represented by general formula (I) are shown below.
但し本発明は以下の化合物に限定されるものではない。However, the present invention is not limited to the following compounds.
I−1
I−4
I−6
0
■
8
■
10
I−1 1
0
0
■−1 2
I−1 3
エー1 4
I−1 5
0
H
■
l6
QM
I−18
■−2 0
H
■
23
■
24
■
25
■−2 6
S}l
本発明に用いられるヒドラジン誘導体としては、上記の
ものの他に、RESEARCH DISCLOSURE
Item23516 (1983年11月号、P.3
46)およびそこに引用された文献の他、米国特許4,
080,207号、同4,269,929号、同4,2
76,364号、同4,278,748号、同4,38
5,108号、同4,459,347号、同4,560
,638号、同4, 478, 928号、英国特許
2,Oil,391B,特開昭60−179734号、
同62−270,948号、同63−29.751号、
同61−170,733号、同61−270,744号
、同62−948号、EP217,310号、またはU
S 4,686,167号、特開昭62−178,24
6号、同63−32,538号、同63−104,04
7号、同63−121、838号、同63−129,3
37号、同63−223,744号、同63−234,
244号、同63−234,245号、同63−234
,246号、同63−294,552号、同63−30
6.438号、特開平1−100,530号、同1−1
05,941号、同1−105,943号、特開昭64
−lO,233号、特開平1−90,439号、特願昭
63−105,682号、同63−114,118号、
同63−110,051号、同63−114,119号
、同63−116,239号、同63−147,339
号、同63−179,760号、同63−229.16
3号、特願平1−18,377号、同1−18,378
号、同1−18,379号、同1−15,755号、同
1−16,814号、同1−40,792号、同1−4
2,615号、同1−42.616号、同1−123.
693号、同1−126,284号に記載されたものを
用いることができる。I-1 I-4 I-6 0 ■ 8 ■ 10 I-1 1 0 0 ■-1 2 I-1 3 A1 4 I-1 5 0 H ■ l6 QM I-18 ■-2 0 H ■ 23 ■ 24 ■ 25 ■-2 6 S}l In addition to the above-mentioned hydrazine derivatives used in the present invention, RESEARCH DISCLOSURE
Item23516 (November 1983 issue, P.3
46) and the documents cited therein, as well as U.S. Pat.
No. 080,207, No. 4,269,929, No. 4,2
No. 76,364, No. 4,278,748, No. 4,38
No. 5,108, No. 4,459,347, No. 4,560
, No. 638, No. 4,478, 928, British Patent No. 2, Oil, 391B, JP-A-60-179734,
No. 62-270,948, No. 63-29.751,
61-170,733, 61-270,744, 62-948, EP217,310, or U
S 4,686,167, JP-A-62-178,24
No. 6, No. 63-32,538, No. 63-104,04
No. 7, No. 63-121, No. 838, No. 63-129, 3
No. 37, No. 63-223, 744, No. 63-234,
No. 244, No. 63-234, 245, No. 63-234
, No. 246, No. 63-294, 552, No. 63-30
6.438, JP-A No. 1-100,530, JP-A No. 1-1
No. 05,941, No. 1-105,943, JP-A-64
-lO, No. 233, Japanese Patent Application Publication No. 1-90,439, Japanese Patent Application No. 105,682/1982, No. 114,118/1983,
No. 63-110,051, No. 63-114,119, No. 63-116,239, No. 63-147,339
No. 63-179,760, No. 63-229.16
No. 3, Patent Application No. 1-18,377, No. 1-18,378
No. 1-18,379, No. 1-15,755, No. 1-16,814, No. 1-40,792, No. 1-4
No. 2,615, No. 1-42.616, No. 1-123.
693 and 1-126,284 can be used.
本発明におけるヒドラジン誘導体の添加量としてはハロ
ゲン化銀1モルあたり1×10−’モルないし5X10
−2モル含有されるのが好ましく、特にlX10−’モ
ルないし2X10−”モルの範囲が好ましい添加量であ
る。The amount of the hydrazine derivative added in the present invention is from 1 x 10-' mol to 5 x 10-' mol per mol of silver halide.
-2 mol is preferable, and a particularly preferable addition amount is in the range of 1×10-' mol to 2×10-'' mol.
本発明の酸化されることにより現像抑制剤を放出しうる
レドックス化合物について説明する。The redox compound of the present invention that can release a development inhibitor when oxidized will be explained.
本発明のレドックス化合物として特に好ましいものは以
下の一般式(n)で表わされる化合物である。Particularly preferred redox compounds of the present invention are compounds represented by the following general formula (n).
一般式(It)
式中、R
は脂肪族基または芳香族基を表わし、
O
11
G1は−C一基、一S02一基、一S〇一基、O
11
−P一基、又はイミノメチレン基を表わし、R2R2
はアルコキシ基、アリールオキシ基、アミノ基を表わす
。General formula (It) In the formula, R represents an aliphatic group or an aromatic group, and O 11 G1 is -C group, -S02 group, -S〇 group, O 11 -P group, or iminomethylene R2R2 represents an alkoxy group, an aryloxy group, or an amino group.
B. 、B2はともに水素原子あるいは一方が水素原子
で他方が置換もしくは無置換のアルキルスルホニル基、
又は置換もしくは無置換のアリールスルホニル基、又は
置換もしくは無置換のアシル基を表わす。Timeは二
価の連結基を表わし、tは0または1を表わす。PUG
は現像抑制剤を表わす。B. , B2 are both hydrogen atoms, or one is a hydrogen atom and the other is a substituted or unsubstituted alkylsulfonyl group,
or a substituted or unsubstituted arylsulfonyl group, or a substituted or unsubstituted acyl group. Time represents a divalent linking group, and t represents 0 or 1. PUG
represents a development inhibitor.
一般式(II)の化合物についてさらに詳細について説
明する。The compound of general formula (II) will be explained in further detail.
一般式(n)において、R,で表される脂肪族基は好ま
しくは炭素数1〜30のものであって、特に炭素数1〜
20の直鎖、分岐または環状のアルキル基である。この
アルキル基は置換基を有していてもよい。In the general formula (n), the aliphatic group represented by R preferably has 1 to 30 carbon atoms, particularly 1 to 30 carbon atoms.
20 straight chain, branched or cyclic alkyl groups. This alkyl group may have a substituent.
一般式(n)においてR1で表される芳香−族基は単環
または2環のアリール基または不飽和へテロ環基である
。ここで不飽和へテロ環基はアリール基と縮合してヘテ
ロアリール基を形或してもよい。In the general formula (n), the aromatic group represented by R1 is a monocyclic or bicyclic aryl group or an unsaturated heterocyclic group. Here, the unsaturated heterocyclic group may be fused with an aryl group to form a heteroaryl group.
例えばベンゼン環、ナフタレン環、ビリジン環、キノリ
ン環、イソキノリン環等があるがなかでもベンゼン環を
含むものが好ましい。Examples include a benzene ring, a naphthalene ring, a pyridine ring, a quinoline ring, and an isoquinoline ring, among which those containing a benzene ring are preferred.
R,として特に好ましいものはアリール基である。Particularly preferred as R is an aryl group.
R,のアリール基または不飽和へテロ環基は置換されて
いてもよく、代表的な置換基としては、例えばアルキル
基、アラルキル基、アルケニル基、アルキニル基、アル
コキシ基、アリール基、置換アミノ基、ウレイド基、ウ
レタン基、アリールオキシ基、スルファモイル基、カル
バモイル基、アルキルチオ基、アリールチオ基、スルホ
ニル基、スルフィニル基、ヒドロキシ基、ハロゲン原子
、シアノ基、スルホ基、アリールオキシカルボニル基、
アシル基、アルコキシカルボニル基、アシルオキシ基、
カルポンアミド基、スルホンアミド基、カルボキシル基
、リン酸アミド基などが挙げられ、好ましい置換基とし
ては直鎖、分岐または環状のアルキル基(好ましくは炭
素数1〜20のもの)、アラルキル基(好ましくは炭素
数7〜30のもの)アルコキシ基(好ましくは炭素数1
〜30のもの)置換アミノ基(好ましくは炭素数1〜3
0のアルキル基で置換さ社たアミノ基)、アシルアミノ
基(好ましくは炭素数2〜40を持つもの)、スルホン
アミド基(好ましくは炭素数1〜40を持つもの)、ウ
レイド基(好ましくは炭素数I〜40を持つもの、リン
酸アミド基(好ましくは炭素数1〜40のもの)などで
ある。The aryl group or unsaturated heterocyclic group of R may be substituted, and typical substituents include an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an aryl group, and a substituted amino group. , ureido group, urethane group, aryloxy group, sulfamoyl group, carbamoyl group, alkylthio group, arylthio group, sulfonyl group, sulfinyl group, hydroxy group, halogen atom, cyano group, sulfo group, aryloxycarbonyl group,
Acyl group, alkoxycarbonyl group, acyloxy group,
Examples include carponamide group, sulfonamide group, carboxyl group, phosphoric acid amide group, etc. Preferred substituents include linear, branched or cyclic alkyl group (preferably one having 1 to 20 carbon atoms), aralkyl group (preferably (having 7 to 30 carbon atoms) alkoxy group (preferably 1 carbon number)
~30) substituted amino group (preferably 1 to 3 carbon atoms)
an acylamino group (preferably having 2 to 40 carbon atoms), a sulfonamide group (preferably having 1 to 40 carbon atoms), a ureido group (preferably having 1 to 40 carbon atoms), Examples include those having a number of I to 40, and phosphoric acid amide groups (preferably those having a carbon number of 1 to 40).
O
11
一般式(n)のG.とじては一〇一基が最も好ましく、
A,、A2としては水素原子が最も好ましい。O 11 G. of general formula (n) For closing, 101 is the most preferable;
A hydrogen atom is most preferable as A,, A2.
Timeで表わされる二価の連結基としては、例えば米
国特許第4,248,962号(特開昭54−145,
135号)等に記載のp−ニトロフエノキシ誘導体の分
子内開環反応によって写真的有用基(PUG)を放出す
るもの;米国特許第4,310,612号(特開昭55
−53,330号)および同4,358,252号等に
記載の環開裂後の分子内閉環反応によってPUGを放出
するもの;米国特許第4,330,617号、同4,4
46,216号、同4,483,919号、特開昭59
−121,328号等に記載のコハク酸モノエステルま
たはその類縁体のカルボキシル基の分子内閉環反応によ
る酸無水物の生成を伴って、PUGを放出するもの;米
国特許第4,409,323号、同4,421,845
号、リサーチ・ディスクロージャー誌N[12 1,
228 (1981年12月)、米国特許第4,41
6,977号(特開昭57−135.944号)、特開
昭58−209,736号、同58−209,738号
等に記載のアリールオキシ基またはへテロ環オキシ基が
共役した二重結合を介した電子移動によりキノモノメタ
ン、またはその類縁体を生或してPUGを放出するもの
;米国特許第4.420,554号(特開昭57−13
6,640号)、特開昭57−135,945号、同5
7−188,035号、同58−98,728号および
同58−209,737号等に記載の含窒素へテロ環の
エナミン構造を有する部分の電子移動によりエナミンの
γ位よりPUGを放出するもの;特開昭57−56.8
37号に記載の含窒素へテロ環の窒素原子と共役したカ
ルポニル基への電子移動により生成したオキシ基の分子
内開環反応によりPUGを放出するもの;米国特許第4
. 146, 396号(特開昭5 2−9 0
9 3 2号)、特開昭59−93,442号、特開昭
59−75475号等に記載のアルデヒド類の生成を伴
ってPUGを放出するもの;特開昭51−146,82
8号、同57−179,842号、同59−104,6
41号に記載のカルボキシル基の脱炭素を伴ってPUG
を放出するもの,−0−COOCR.R.−PUGの構
造を有し、脱炭酸と引き続くアルデヒド類の生成を伴っ
てPUGを放出するもの;特開昭60−7,429号に
記載のイソシアナートの生成を伴ってPUGを放出する
もの;米国特許第4,438,193号等に記載のカラ
ー現像薬の酸化体とのカップリング反応によりPUGを
放出するものなどを挙げることができる。As the divalent linking group represented by Time, for example, U.S. Pat.
No. 135) etc., which release a photographically useful group (PUG) through an intramolecular ring-opening reaction of a p-nitrophenoxy derivative; US Pat.
-53,330) and U.S. Pat. No. 4,358,252, which release PUG by intramolecular ring closure reaction after ring opening; U.S. Pat.
No. 46,216, No. 4,483,919, JP-A-59
U.S. Patent No. 4,409,323, which releases PUG with the production of acid anhydride through the intramolecular ring-closing reaction of the carboxyl group of the succinic acid monoester or its analog described in US Patent No. 121,328, etc. , 4,421,845
No., Research Disclosure Magazine N[12 1,
228 (December 1981), U.S. Patent No. 4,41
6,977 (JP-A-57-135.944), JP-A-58-209,736, JP-A-58-209,738, etc. Generates quinomonomethane or its analogues and releases PUG by electron transfer via heavy bonds; US Pat.
6,640), JP-A No. 57-135,945, No. 5
7-188,035, 58-98,728, 58-209,737, etc., PUG is released from the γ-position of the enamine by electron transfer of the part having the enamine structure of the nitrogen-containing heterocycle. Item: Japanese Patent Application Publication No. 1987-56.8
No. 37, which releases PUG through an intramolecular ring-opening reaction of an oxy group generated by electron transfer to a carbonyl group conjugated with the nitrogen atom of a nitrogen-containing heterocycle; US Pat. No. 4
.. No. 146, 396 (Unexamined Japanese Patent Publication No. 1973 2-9 0
9 3 2), JP-A-59-93,442, JP-A-59-75475, etc., which release PUG with the production of aldehydes; JP-A-51-146,82
No. 8, No. 57-179,842, No. 59-104,6
PUG with decarbonization of the carboxyl group described in No. 41
-0-COOCR. R. - A substance having the structure of PUG and releasing PUG with decarboxylation and subsequent production of aldehydes; a substance releasing PUG with production of isocyanate as described in JP-A-60-7,429; Examples include those that release PUG through a coupling reaction with an oxidized product of a color developer described in US Pat. No. 4,438,193 and the like.
これら、Timeで表わされる二価の連結基の具体例に
ついては特開昭61−236,549号、特願昭63−
98,803号等にも詳細に記載されている。For specific examples of these divalent linking groups represented by Time, see JP-A No. 61-236,549 and Japanese Patent Application No. 63-Sho.
It is also described in detail in No. 98,803.
PUGは(Time−}+PUGまたはPUGとして現
像抑制効果を有する基を表わす。PUG represents a group having a development inhibiting effect as (Time-}+PUG or PUG.
PUGまたは(T i m e+,P UGで表わされ
る現像抑制剤はへテロ原子を有し、ヘテロ原子を介して
結合している公知の現像抑制剤であり、これらはたとえ
ばシー・イー・ケー・ミース(C.E.K.Mees)
及びテー・エッチ・ジェームズ(T.H.James)
著「ザ・セオリー・オブ・ザ・フォトグラフィック●プ
ロセス(The Theory of Photogr
ap−hic Processes)J第3版、196
6マクミラン(Macmi11an)社刊、344頁〜
346頁などに記載されている。The development inhibitor represented by PUG or (T im e+, P UG is a known development inhibitor that has a heteroatom and is bonded via a heteroatom. Mees (C.E.K.Mees)
and T.H. James
Author: “The Theory of Photographic Process”
ap-hic Processes) J 3rd edition, 196
6 Published by Macmillan, pp. 344~
It is described on page 346 etc.
PUGで表わされる現像抑制剤は置換されていてもよい
。置換基の例としては例えばR’の置換基として列挙し
たものが挙げられ、これらの基はさらに置換されていて
もよい。The development inhibitor represented by PUG may be substituted. Examples of substituents include those listed as substituents for R', and these groups may be further substituted.
好ましい置換基としてはニトロ基、スルホ基、カルボキ
シル基、スルファモイル基、ホスホノ基、ホスフィニコ
基、スルホンアミド基である。Preferred substituents include a nitro group, a sulfo group, a carboxyl group, a sulfamoyl group, a phosphono group, a phosphinico group, and a sulfonamide group.
また一般式(IF)において、R1または十Time−
)−+PUGは、その中にカプラー等の不動性写真用添
加剤において常用されているバラスト基や一般式(II
)で表わされる化合物がハロゲン化銀に吸着することを
促進する基が組み込まれていてもよい。Further, in the general formula (IF), R1 or 10 Time-
)-+PUG contains a ballast group commonly used in immobile photographic additives such as couplers and general formula (II
) may be incorporated with a group that promotes adsorption of the compound represented by () to silver halide.
バラスト基は一般式(n)で表わされる化合物が実質的
に他層または処理液中へ拡散できないようにするのに十
分な分子量を与える有機基であり、アルキル基、アリー
ル基、ヘテロ環基、エーテル基、チオエーテル基、アミ
ド基、ウレイド基、ウレタン基、スルホンアミド基など
の一つ以上の組合せからなるものである。バラスト基と
して好ましくは置換ベンゼン環を有するバラスト基であ
り、特に分岐状アルキル基で置換されたベンゼン環を有
するバラスト基が好ましい。The ballast group is an organic group that provides a sufficient molecular weight to substantially prevent the compound represented by the general formula (n) from diffusing into other layers or the processing solution, and includes an alkyl group, an aryl group, a heterocyclic group, It consists of a combination of one or more of an ether group, a thioether group, an amide group, a ureido group, a urethane group, a sulfonamide group, etc. The ballast group is preferably a ballast group having a substituted benzene ring, particularly a ballast group having a benzene ring substituted with a branched alkyl group.
ハロゲン化銀への吸着促進基としては、具体的には4−
チアゾリン−2−チオン、4−イミダゾリンー2−チオ
ン、2−チオヒダントイン、ローダニン、チオバルビツ
ール酸、テトラゾリン−5一チオン、1, 2.
4−トリアゾリン−3−チオン、l, 3. 4−
オキサゾリン−2−チオン、ペンズイミダゾリン−2−
チオン、ペンズオキサゾリン−2−チオン、ペンゾチア
ゾリン−2−チオン、チオトリアジン、1,3−イミダ
ゾリンー2ーチオンのような環状チオアミド基、鎖状チ
オアミド基、脂肪族メルカプト基、芳香族メルカプト基
、ヘテロ環メルカプト基(−SH基が結合した炭素原子
の隣が窒素原子の場合はこれと互変異性体の関係にある
環状チオアミド基と同義であり、この基の具体例は上に
列挙したものと同じである。)、ジスルフィド結合を有
する基、ペンゾトリアゾール、トリアゾール、テトラゾ
ール、インダゾール、ペンズイミダゾール、イミダゾー
ル、ペンゾチアゾール、チアゾール、チアゾリン、ペン
ゾオキサゾール、オキサゾール、オキサゾリン、チアジ
アゾール、オキサチアゾール、トリアジン、アザインデ
ンのような窒素、酸素、硫黄及び炭素の組合せからなる
5員ないし6員の含窒素へテロ環基、及びペンズイミダ
ゾリニウムのような複素環四級塩などが挙げられる。Specifically, the adsorption promoting group to silver halide is 4-
Thiazoline-2-thione, 4-imidazoline-2-thione, 2-thiohydantoin, rhodanine, thiobarbituric acid, tetrazoline-5-thione, 1, 2.
4-triazoline-3-thione, l, 3. 4-
Oxazoline-2-thione, penzimidazoline-2-
cyclic thioamide group, linear thioamide group, aliphatic mercapto group, aromatic mercapto group, hetero- Cyclic mercapto group (if the carbon atom to which the -SH group is bonded is a nitrogen atom, it has the same meaning as a cyclic thioamide group that has a tautomeric relationship with this group, and specific examples of this group are those listed above. ), a group having a disulfide bond, penzotriazole, triazole, tetrazole, indazole, penzimidazole, imidazole, penzothiazole, thiazole, thiazoline, penzoxazole, oxazole, oxazoline, thiadiazole, oxathiazole, triazine, Examples include a 5- to 6-membered nitrogen-containing heterocyclic group consisting of a combination of nitrogen, oxygen, sulfur, and carbon such as azaindene, and a heterocyclic quaternary salt such as penzimidazolinium.
これらはさらに適当な置換基で置換されていてもよい。These may be further substituted with a suitable substituent.
置換基としては、例えばR1の置換基として述ベたもの
が挙げられる。Examples of the substituent include those mentioned as the substituent for R1.
以下に本発明に用いられる化合物の具体例を列記するが
本発明はこれに限定されるものではない。Specific examples of compounds used in the present invention are listed below, but the present invention is not limited thereto.
It−1
S
[−3
q
Not
n−5
11−6
n−7
n−8
■−1 1
■
l2
q
■−1 4
■−1 5
Now
[[−17
■−1 8
■
l9
q
H
IF−20
I1−2 1
■
22
■
23
■−2 4
0
NO,
■−2 5
■−2 6
■−2 7
0
0
)
.llU3Na
■−2 8
■
29
本発明に用いられるレドックス化合物としては上記のも
のの他に、例えば特開昭61−213,847号、同6
2−260,153号、特願平l−102.393号、
同1−102.394号、同1−102,395号、同
1−114,455号に記載されたものを用いることが
できる。It-1 S [-3 q Not n-5 11-6 n-7 n-8 ■-1 1 ■ l2 q ■-1 4 ■-1 5 Now [[-17 ■-1 8 ■ l9 q H IF -20 I1-2 1 ■ 22 ■ 23 ■-2 4 0 NO, ■-2 5 ■-2 6 ■-2 7 0 0 ) . llU3Na ■-2 8 ■29 In addition to the above-mentioned redox compounds used in the present invention, for example, JP-A-61-213,847 and JP-A-61-213,847,
No. 2-260,153, patent application No. 1-102.393,
Those described in No. 1-102.394, No. 1-102,395, and No. 1-114,455 can be used.
本発明に用いられるレドックス化合物の合成法は例えば
特開昭61−213.847号、同62−260.15
3号、米国特許第4, 684. 604号、特願
昭63−98.803号、米国特許第3,379,52
9号、同3,620,746号、同4,377,634
号、同4, 332, 878号、特開昭49−12
9,536号、同56−153.336号、同56−1
53.342号などに記載されている。Examples of the synthesis method of the redox compound used in the present invention include JP-A-61-213.847 and JP-A-62-260.15.
No. 3, U.S. Pat. No. 4,684. No. 604, Japanese Patent Application No. 63-98.803, U.S. Patent No. 3,379,52
No. 9, No. 3,620,746, No. 4,377,634
No. 4, 332, 878, JP-A-49-12
No. 9,536, No. 56-153.336, No. 56-1
53.342 etc.
本発明のレドックス化合物は、ハロゲン化銀1モルあた
りI X l O” 〜5 X 1 0−”モル、より
好ましくは1×10−5〜1×10−’モルの範囲内で
用いられる。The redox compound of the present invention is used in an amount of IXlO'' to 5X10-'' mol, more preferably 1 x 10-5 to 1 x 10-' mol, per mol of silver halide.
本発明のレドックス化合物は、適当な水混和性有機溶媒
、例えば、アルコール類(メタノール、エタノール、プ
ロパノール、フッ素化アルコール)ケトン類(アセトン
、メチルエチルケトン)、ジメチルホルムアミド、ジメ
チルスルホキシド、メチルセルソルブなどに溶解して用
いることができる。The redox compound of the present invention can be dissolved in a suitable water-miscible organic solvent, such as alcohols (methanol, ethanol, propanol, fluorinated alcohols), ketones (acetone, methyl ethyl ketone), dimethyl formamide, dimethyl sulfoxide, methyl cellosolve, etc. It can be used as
また、既に良く知られている乳化分散法によって、ジブ
チルフタレート、トリクレジルフォスフ工一ト、グリセ
リルトリアセテートあるいはジエチルフタレートなどの
オイル、酢酸エチルやシクロヘキサノンなどの補助溶媒
を用いて溶解し、機械的に乳化分散物を作成して用いる
こともできる。In addition, by the well-known emulsification dispersion method, dibutyl phthalate, tricresyl phosphate, glyceryl triacetate or diethyl phthalate can be dissolved using oils, auxiliary solvents such as ethyl acetate or cyclohexanone, and mechanically An emulsified dispersion can also be prepared and used.
あるいは固体分散法として知られている方法によって、
レドックス化合物の粉末を水の中にポールミル、コロイ
ドミル、あるいは超音波によって分散して用いることも
できる。Alternatively, by a method known as solid dispersion method,
The redox compound powder can also be dispersed in water using a pole mill, colloid mill, or ultrasonic wave.
写真乳剤の結合剤または保護コロイドとしては、ゼラチ
ンを用いるのが有利であるが、それ以外の親水性コロイ
ドも用いることができる。たとえばゼラチン誘導体、ゼ
ラチンと他の高分子とのグラフトポリマー、アルブミン
、カゼイン等の蛋白質ヒドロキシエチルセルロース、カ
ルボキシメチルセルロース、セルロース硫酸エステル類
等の如きセルロース誘導体、アルギン酸ソーダ、澱粉誘
導体などの糖誘導体、ポリビニルアルコール、ポリビニ
ルアルコール部分アセタール、ポリーN−ビニルピロリ
ドン、ポリアクリル酸、ポリメタクリル酸、ポリアクリ
ルアミド、ポリビニルイミダゾール、ポリビニルビラゾ
ール等の単一あるいは共重合体の如き多種の合成親水性
高分子物質を用いることができる。Gelatin is advantageously used as a binder or protective colloid in photographic emulsions, but other hydrophilic colloids can also be used. For example, gelatin derivatives, graft polymers of gelatin and other polymers, proteins such as albumin and casein, cellulose derivatives such as hydroxyethyl cellulose, carboxymethyl cellulose, and cellulose sulfate esters, sugar derivatives such as sodium alginate and starch derivatives, polyvinyl alcohol, A wide variety of synthetic hydrophilic polymeric materials can be used, such as single or copolymers of polyvinyl alcohol partial acetal, polyN-vinylpyrrolidone, polyacrylic acid, polymethacrylic acid, polyacrylamide, polyvinylimidazole, polyvinylvirazole, etc. can.
ゼラチンとしては石灰処理ゼラチンのほか、酸処理ゼラ
チンを用いてもよく、ゼラチン加水分解物、ゼラチン酵
素分解物も用いることかできる。As the gelatin, in addition to lime-treated gelatin, acid-treated gelatin may be used, and gelatin hydrolysates and gelatin enzymatically decomposed products may also be used.
本発明に用いられる感光材料には、感度上昇を目的とし
て特開昭55−52050号第45頁〜53頁に記載さ
れた増感色素(例えばシアニン色素、メロシアニン色素
など)を添加することができる。Sensitizing dyes (e.g., cyanine dyes, merocyanine dyes, etc.) described in JP-A No. 55-52050, pages 45 to 53, can be added to the light-sensitive material used in the present invention for the purpose of increasing sensitivity. .
これらの増感色素は単独に用いてもよいが、それらの組
合せを用いてもよく、増感色素の組合せは特に、強色増
感の目的でしばしば用いられる。These sensitizing dyes may be used alone or in combination, and combinations of sensitizing dyes are often used particularly for the purpose of supersensitization.
増感色素とともに、それ自身分光増感作用をもたない色
素あるいは可視光を実質的に吸収しない物質であって、
強色増感を示す物質を乳剤中に含んでもよい。Along with the sensitizing dye, it is a dye that itself does not have a spectral sensitizing effect or a substance that does not substantially absorb visible light,
A substance exhibiting supersensitization may also be included in the emulsion.
有用な増感色素、強色増感を示す色素の組合せ及び強色
増感を示す物質はリサーチ・ディスクロージ+ (Re
search Disclosure) 1 7 6巻
l7643(1978年12月発行)第23頁■のJ項
に記載されている。Useful sensitizing dyes, dye combinations exhibiting supersensitization, and substances exhibiting supersensitization are listed in Research Disclosure+ (Re
Search Disclosure) 176 Vol. 17643 (published December 1978), page 23, Section J.
本発明の感光材料には、感光材料の製造工程、保存中あ
るいは写真処理中のカブリを防止しあるいは写真性能を
安定化させる目的で、種々の化合物を含有させることが
できる.すなわちアゾール頬たとえばペンゾチアゾリウ
ム塩、ニトロインダゾール類、クロロベンズイミダゾー
ル頬、プロモベンズイξ゛ダゾール類、メルカブトテト
ラゾール類、メルカプトチアゾール類、メルカブトベン
ゾチアゾール類、メルカブトチアジアゾール類、アミノ
トリアゾール頬、ペンゾチアゾール類、ニトロベンゾト
リアゾール類、など;メルカブトビリミジンvX:メル
カプトトリアジン頬;たとえばオキサゾリンチオンのよ
うなチオーケト化合物;アザインデン類、たとえばトリ
アヂインデン類、テトラアザインデンvR(特に4−ヒ
ドロキシ置換(1,3,3a,7)テトラザインデン類
)、ペンタアザインデン類など;ベンゼンチオスル7オ
ン酸、ベンゼンスルフィン酸、ベンゼンスルフォン酸ア
ミド等のようなカブリ防止剤または安定剤として知られ
た多くの化,金物を加えることができる.これらのもの
の中で、好ましくはペンゾトリアゾール(例えば、5−
メチルーベンゾトリアゾール)及びニトロインダゾール
類(例えば5一二トロインダゾール)である.また、こ
れらの化合物を処理液に含有させてもよい.さらに特開
昭62−30243に記載の現像中に抑制剤を放出する
ような化合物を、安定剤あるいは黒ボツ防止の目的で含
有させることができる.
本発明の写真感光材料には安定剤、促進剤等種々の目的
でハイドロキノン誘導体、フェニドン誘導体などの現像
主薬を含有することができる.本発明の写真感光材料に
は、写真乳剤層その他の親水性゛コロイド層に無機また
は有機の硬膜剤を含有してよい.例えばクロム塩(クロ
ムミゴウバン、酢酸クロムなど)、アルデヒド類、(ホ
ルムアルデヒド、グルタールアルデヒドなど)、Nーメ
チロール化合物(ジメチロール尿素など)、ジオキサン
誘導体、活性ビニル化合物(1,3.5一トリアクリロ
イルーへキサヒドローS−}リアジン、l,3−ビニル
スルホニル−2−プロパノールなど)、活性ハロゲン化
合物(2.4−.ジクロル−6−ヒドロキシーS−トリ
アジンなど)、ムコハロゲン酸類(ムコクロル酸など)
、などを単独または組み合わせて用いることができる.
本発明を用いて作られる感光材料の写真乳剤層または他
の親水性コロイド層には塗布助剤、帯電防止、スベリ性
改良、乳化分散、接着防止及び写真特性改良(例えば、
現像促進、硬調化、増感)等種々の百的で、種々の界面
活性剤を含んでもよい.
例えばサボニン(ステロイド系〉、アルキレンオキサイ
ド誘導体(例えばポリエチレングリコール、ポリエチレ
ングリコール/ポリプロピレングリコール縮合物、ボリ
エチレングリコールアルキルエーテル類又はポリエチレ
ングリコールアルキルアリールエーテル類、ポリエチレ
ングリコールエステル類、ポリエチレングリコールソル
ビクンエステル類、ポリアルキレングリコールアルキル
アミン又はアミド頻、シリコーンのポリエチレンオキサ
イド付加物類)、グリシドール誘導体(例えばアルケニ
ルコハク酸ポリグリセリド、アルキルフェノールボリグ
リセリド)、多価アルコールの脂肪酸エステル頬、等の
アルキルエステル類などの非イオン性界面活性剤;アル
キルカルボン酸塩、アルキルスルフォン酸塩、アルキル
ベンゼンスルフォン酸塩、アルキルナフタレンスルフォ
ン酸塩、アルキル硫酸エステル趙、アルキルリン酸エス
テル!、N−アシルーN−アルキルタウリン類、スルホ
コハク酸エステル類、スルホアルキルボリオキシエチレ
ンアルキルフェニルエーテル類、ポリオキシエチレンア
ルキルリン酸エステルMなどのような、カルボキシ基、
スルホ基、ホスホ蟇、硫酸エステル基、リン酸エステル
基等の酸性基を含むアニオン界面活性剤;アミノ酸類、
アミノアルキルスルホン酸類、アミノアルキル硫酸又は
リン酸エステル頬、アルキルベタイン類、アミンオキシ
ド類などの両性界面活性剤;アルキルアミン塩類、脂肪
族あるいは芳香族第4級アンモニウム塩類、ピリジニウ
ム、イξダゾリウムなどの複素環第4級アンモニウム塩
類、及び脂肪族又は複素環を含むホスホニウム又はスル
ホニウム塩類などのカチオン界面活性剤を用いることが
できる.特に本発明において好ましく用いられる界面活
性剤ぱ特公昭58−9412号公報に記載された分子量
600以上のポリアルキレンオキサイド類である.
また、帯電防止のためには特開昭60−80849号な
どに記載された含フッ素系界面活性剤を用いることが好
ましい.
本発明の写真感光材料には、写真乳剤層その他の親水性
コロイド層に現像時画像の濃度に対応して、現像抑制剤
を放出するハイドロキノン誘導体(いわゆる、DIR−
ハイドロキノン)を含有してもよい.
それらの具体例は米国特許3,379,529号、米国
特許3,620.746号、米国特許4,377,63
4号、米国特許4,332,878号、侍開昭49−1
29,536号、特開昭54−67。419号、特開昭
56−153,336号、特開昭56−153,342
号、特開昭59−278,853号、同59−9043
5号、同59−90436号、同59−138808号
などに記載の化合物を挙げることができる.本発明の写
真感光材料には写真乳剤層その他の親水性コロイド層に
接着防止の目的でシリカ、酸化マグネシウム、ポリメチ
ルメタクリレート等のマット剤を含むことができる.
本発明で用いられる感光材料には寸度安定性の目的で水
不溶または難溶性合或ポリマーの分散物を含むことがで
きる.たとえばアルキル(メタ)アクリレート、アルコ
キシアクリル(メタ)アクリレート、グリシジル(メタ
)アクリレート、などの単独もしくは組合わせ、または
これらとアクリル酸、メタアクリル酸、などの組合せを
単量体戒分とするポリマーを用いることができる.本発
明の写真感光材料のハロゲン化銀乳剤層及びその他の層
には酸基を有する化合物を含有することが好ましい.酸
基を有する化合物としてはサリチル酸、酢酸、アスコル
ビン酸等の有機酸及びアクリル酸、マレイン酸、フタル
酸の如き酸モノマーをくり返し単位として有するポリマ
ー又はコボリマーを挙げることができる.これらの化合
物に関しては特開昭61−223834号、同61−2
28437号、同62−25745号、及び同62−5
5642号明細書の記録を参考にすることができる.こ
れらの化合物の中でも特に好ましいのは、低分子化合物
としてはアスコルビン酸であり、高分子化合物としては
アクリル酸の如き酸モノマーとジビニルベンゼンの如き
2個以上の不飽和基を有する架橋性モノマーからなるコ
ボリマーの水分散性ラテックスである.
本発明に用いられる乳剤は、適当な支持体、例えばガラ
ス、酢酸、セルロースフィルム、ポリエチレンテレフタ
レートフィルム、紙、バライタ塗覆祇、ポリオレフィン
被覆紙の如きものの上に塗布される.
本発明のハロゲン化銀感光材料を用いて超硬調で高感度
の写真特性を得るには、従来の伝染現像液や米国特許第
2.419.975号に記載されたpH13に近い高ア
ルカリ現像液を用いる必要はなく、安定な現像液を用い
ることができる.すなわち、本発明のハロゲン化銀感光
材料は、保恒剤としての亜硫酸イオンを0.15モル/
l以上含み、pHl0.5〜12.3、特にpH11.
0〜12.0の現像液によって充分に超硬調のネガ画像
を得ることができる.
本発明に使用する現像液に用いる現像主薬には特別な制
限はないが、良好な網点品賞を得やすい点で、ジヒドロ
キシベンゼン類を含むことが好ましく、ジヒドロキシベ
ンゼン頬と1−フェニル−3−ビラゾリドン類の組合せ
またはジヒドロキシベンゼン類とP−アミノフェノール
類の組合せを用いる場合もある.
本発明に用いるジヒドロキシベンゼン現像主薬としては
ハイドロキノン、クロロハイドロキノン、プロムハイド
ロキノン、イソプロビルハイドロキノン、メチルハイド
ロキノン、2.3−ジクロロハイドロキノン、2.5−
ジクロロハイドロキノン、2.3−ジブロムハイドロキ
ノン、2.5−ジメチルハイドロキノンなどがあるが特
にハイドロキノンが好ましい.
本発明に用いる1−フェニル−3−ビラゾリドン又はそ
の誘導体の現像主薬としては1−フェニルー3−ビラゾ
リドン、l−フエニル−4,4ージメチル−4−ビラゾ
リドン、1−フエニルー4一メチル−4−ヒドロキシメ
チル−3−ビラゾリドン、1−7エニル−4.4−ジヒ
ドロキシメチル−3−ビラゾリドン、1−フェニル−5
−メチル−3−ビラゾリドン、1−p−アミノフエニル
−4.4−ジメチル−3−ビラゾリドン、l−p−トリ
ル−4.4−ジメチル−3−ビラゾリドンなどがある.
本発明に用いるp−アミノフェノール系現像主薬として
はN−メチルーp−アミノフェノール、p−アミノフェ
ノール、N−(β−ヒドロキシエチル)−p−アξノフ
ェノール、N−(4−ヒドロキシフェニル)グリシン、
2−メチルーp−アミノフェノール、p−ベンジルアξ
ノフェノール等があるが、なかでもN−メチルーP−ア
ξノフェノールが好ましい.
現像主薬は通常O.OSモル/l〜0.8モル/lの量
で用いられるのが好ましい.またジヒドロキシベンゼン
類と1−フェニル−3−ビラゾリドン類又はP・アミノ
・フェノール類との組合せを用いる場合には前者を0.
05モル/2〜0.5モル/1、後者を0.06モル/
l以下の量で用いるのが好ましい.
本発明に用いる亜硫酸塩の保恒剤としては亜硫酸ナトリ
ウム、亜硫酸カリウム、亜硫酸リチウム、亜硫酸アンモ
ニウム、重亜硫酸ナトリウム、メタ重亜硫酸カリウム、
ホルムアルデヒド重亜硫酸ナトリウムなどがある.亜硫
酸塩は0.15モル/l以上特に0.5モル/l以上が
好ましい.また上限は2.5モル/Ilまでとするのが
好ましい.pHの設定のために用いるアルカリ剤には水
酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭
酸カリウム、第三リン酸ナトリウム、第三リン酸カリウ
ムの如きpHilliff剤や緩衝剤を含む.現像液の
pHはlO.5〜l2.3の間に設定される.
上記威分以外に用いられる添加剤としてはホウ酸、ホウ
砂などの化合物、臭化ナトリウム、臭化カリウム、沃化
カリウムの如き現像抑制剤:エチレングリコール、ジエ
チレングリコール、トリエチレングリコール、ジメチル
ホルムアミド、メチルセロソルフ、ヘキシレングリコー
ル、エタノール、メタノールの如き有機溶M:I−フェ
ニル−5−メルカブトテトラゾール、5−ニトロインダ
ゾール等のインダゾール系化合物、5−メチルベンット
リアゾール等のペンットリアゾール系化合物などのカブ
ワ防止剤又は黒ボッ(black pepper)防止
剤:を含んでもよく、更に必要に応じて色調剤、界面活
性剤、消泡剤、硬水軟化剤、硬膜剤、特開昭56−10
6244号記載のアミノ化合物などを含んでもよい.
本発明の現像液には銀汚れ防止剤して特開昭56−24
.347号に記載の化合物を用いることができる.現倣
液中に添加する溶解助剤して特願昭60−109.74
3号に記載の化合物を用いることができる..さらに現
像液に用いるpH41衝剤として特開昭80−93.4
33号に記載の化合物あるいは特願昭61−28708
号に記載の化合物を用いることができる.
定着剤としては一般に用いられる組成のものを用いるこ
とができる。定着剤としてはチオ硫酸塩、チオシアン酸
塩のほか、定着剤としての効果の知られている有機硫黄
化合物を用いることができる。The light-sensitive material of the present invention may contain various compounds for the purpose of preventing fogging or stabilizing photographic performance during the manufacturing process, storage, or photographic processing of the light-sensitive material. Namely, azole agents such as penzothiazolium salts, nitroindazoles, chlorobenzimidazole agents, promobenziξ'dazoles, mercabutotetrazoles, mercaptothiazoles, mercabutobenzothiazoles, mercabutothiadiazoles, aminotriazole agents, penzothiazoles, nitrobenzotriazoles, etc.; mercaptovirimidine vX: mercaptotriazine; thioketo compounds, such as oxazolinthione; azaindenes, such as triaziindenes, tetraazaindene vR (particularly 4-hydroxy-substituted (1 , 3, 3a, 7) tetrazaindenes), pentaazaindenes, etc.; many known antifoggants or stabilizers such as benzenethiosulfonic acid, benzenesulfinic acid, benzenesulfonic acid amide, etc. and hardware can be added. Among these, preference is given to penzotriazole (e.g. 5-
methyl-benzotriazole) and nitroindazoles (eg, 5-ditroindazole). Furthermore, these compounds may be included in the treatment liquid. Furthermore, a compound that releases an inhibitor during development as described in JP-A No. 62-30243 may be included for the purpose of stabilizing or preventing black spots. The photographic material of the present invention may contain developing agents such as hydroquinone derivatives and phenidone derivatives for various purposes such as stabilizers and accelerators. The photographic material of the present invention may contain an inorganic or organic hardener in the photographic emulsion layer or other hydrophilic colloid layer. For example, chromium salts (chromium acetate, chromium acetate, etc.), aldehydes (formaldehyde, glutaraldehyde, etc.), N-methylol compounds (dimethylol urea, etc.), dioxane derivatives, activated vinyl compounds (1,3.5-triacryloyl-hexahydro) S-}riazine, l,3-vinylsulfonyl-2-propanol, etc.), active halogen compounds (2,4-dichloro-6-hydroxy-S-triazine, etc.), mucohalogen acids (mucochloric acid, etc.)
, etc. can be used alone or in combination.
The photographic emulsion layer or other hydrophilic colloid layer of the light-sensitive material prepared using the present invention may contain coating aids, antistatic properties, smoothness improvement, emulsification dispersion, adhesion prevention, and photographic property improvement (e.g.
It may contain various surfactants for various purposes such as development acceleration, contrast enhancement, sensitization, etc. For example, sabonin (steroids), alkylene oxide derivatives (e.g. polyethylene glycol, polyethylene glycol/polypropylene glycol condensates, polyethylene glycol alkyl ethers or polyethylene glycol alkyl aryl ethers, polyethylene glycol esters, polyethylene glycol sorbicne esters, Non-ionic compounds such as alkylene glycol alkylamines or amides, polyethylene oxide adducts of silicones), glycidol derivatives (e.g. alkenylsuccinic acid polyglycerides, alkylphenol polyglycerides), fatty acid esters of polyhydric alcohols, etc. Surfactant; alkyl carboxylate, alkyl sulfonate, alkylbenzene sulfonate, alkyl naphthalene sulfonate, alkyl sulfate ester, alkyl phosphate!, N-acyl-N-alkyl taurine, sulfosuccinate, Carboxy groups, such as sulfoalkylborioxyethylene alkylphenyl ethers, polyoxyethylene alkyl phosphate M, etc.
Anionic surfactants containing acidic groups such as sulfo groups, phosphorus groups, sulfate ester groups, phosphate ester groups; amino acids;
Ampholytic surfactants such as aminoalkyl sulfonic acids, aminoalkyl sulfates or phosphate esters, alkyl betaines, and amine oxides; alkyl amine salts, aliphatic or aromatic quaternary ammonium salts, pyridinium, idazolium, etc. Cationic surfactants such as heterocyclic quaternary ammonium salts and phosphonium or sulfonium salts containing aliphatic or heterocycles can be used. In particular, the surfactants preferably used in the present invention are polyalkylene oxides having a molecular weight of 600 or more and described in Japanese Patent Publication No. 58-9412. Further, in order to prevent static electricity, it is preferable to use a fluorine-containing surfactant described in JP-A No. 60-80849. The photographic light-sensitive material of the present invention contains hydroquinone derivatives (so-called DIR-
may contain hydroquinone). Specific examples thereof include U.S. Pat. No. 3,379,529, U.S. Pat. No. 3,620.746, and U.S. Pat.
No. 4, U.S. Patent No. 4,332,878, Samurai Kaisho 49-1
29,536, JP 54-67.419, JP 56-153,336, JP 56-153,342
No., JP-A No. 59-278,853, JP-A No. 59-9043
Examples include compounds described in No. 5, No. 59-90436, and No. 59-138808. The photographic material of the present invention may contain a matting agent such as silica, magnesium oxide, or polymethyl methacrylate in the photographic emulsion layer or other hydrophilic colloid layer for the purpose of preventing adhesion. The light-sensitive material used in the present invention may contain a dispersion of a water-insoluble or poorly soluble synthetic or polymer for the purpose of dimensional stability. For example, polymers containing alkyl (meth)acrylate, alkoxy acrylic (meth)acrylate, glycidyl (meth)acrylate, alone or in combination, or a combination of these with acrylic acid, methacrylic acid, etc. as monomers. It can be used. It is preferable that the silver halide emulsion layer and other layers of the photographic light-sensitive material of the present invention contain a compound having an acid group. Examples of compounds having acid groups include polymers or copolymer having repeating units of organic acids such as salicylic acid, acetic acid, and ascorbic acid, and acid monomers such as acrylic acid, maleic acid, and phthalic acid. Regarding these compounds, see JP-A-61-223834 and JP-A-61-2.
No. 28437, No. 62-25745, and No. 62-5
The record in Specification No. 5642 can be referred to. Among these compounds, particularly preferred is ascorbic acid as a low-molecular compound, and as a high-molecular compound, an acid monomer such as acrylic acid and a crosslinking monomer having two or more unsaturated groups such as divinylbenzene are particularly preferred. This is a water-dispersible latex of cobolimer. The emulsions used in this invention are coated onto a suitable support such as glass, acetic acid, cellulose film, polyethylene terephthalate film, paper, baryta coated paper, polyolefin coated paper, and the like. In order to obtain photographic characteristics of ultra-high contrast and high sensitivity using the silver halide photosensitive material of the present invention, it is necessary to use a conventional infectious developer or a highly alkaline developer with a pH close to 13 as described in U.S. Pat. No. 2,419,975. There is no need to use a stable developer; instead, a stable developer can be used. That is, the silver halide photosensitive material of the present invention contains 0.15 mol/sulfite ion as a preservative.
1 or more, pH 0.5 to 12.3, especially pH 11.
A sufficiently high-contrast negative image can be obtained using a developing solution of 0 to 12.0. Although there are no particular restrictions on the developing agent used in the developer used in the present invention, it is preferable that it contains dihydroxybenzenes, since it is easy to obtain a good halftone score. - A combination of virazolidones or a combination of dihydroxybenzenes and P-aminophenols may be used. The dihydroxybenzene developing agent used in the present invention includes hydroquinone, chlorohydroquinone, promhydroquinone, isopropylhydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, 2,5-
Examples include dichlorohydroquinone, 2,3-dibromohydroquinone, and 2,5-dimethylhydroquinone, with hydroquinone being particularly preferred. As the developing agent for 1-phenyl-3-virazolidone or its derivative used in the present invention, 1-phenyl-3-virazolidone, 1-phenyl-4,4-dimethyl-4-virazolidone, 1-phenyl-4-methyl-4-hydroxymethyl -3-virazolidone, 1-7enyl-4,4-dihydroxymethyl-3-virazolidone, 1-phenyl-5
Examples include -methyl-3-virazolidone, 1-p-aminophenyl-4,4-dimethyl-3-virazolidone, and l-p-tolyl-4,4-dimethyl-3-virazolidone. Examples of the p-aminophenol developing agent used in the present invention include N-methyl-p-aminophenol, p-aminophenol, N-(β-hydroxyethyl)-p-anophenol, and N-(4-hydroxyphenyl). glycine,
2-Methyl-p-aminophenol, p-benzyl ξ
Among them, N-methyl-P-aξnophenol is preferred. The developing agent is usually O. It is preferably used in an amount of OS mol/l to 0.8 mol/l. In addition, when using a combination of dihydroxybenzenes and 1-phenyl-3-virazolidones or P-amino-phenols, the former is 0.
05 mol/2 to 0.5 mol/1, the latter 0.06 mol/1
It is preferable to use it in an amount of 1 liter or less. Preservatives for sulfite used in the present invention include sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfite, potassium metabisulfite,
Examples include formaldehyde and sodium bisulfite. The amount of sulfite is preferably 0.15 mol/l or more, particularly 0.5 mol/l or more. The upper limit is preferably 2.5 mol/Il. Alkaline agents used to set pH include pHlliffing agents and buffers such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, tribasic sodium phosphate, and tribasic potassium phosphate. The pH of the developer is lO. It is set between 5 and 12.3. Additives used in addition to the above ingredients include compounds such as boric acid and borax, development inhibitors such as sodium bromide, potassium bromide, and potassium iodide; ethylene glycol, diethylene glycol, triethylene glycol, dimethylformamide, and methyl cellosol. , hexylene glycol, ethanol, methanol, and other organic solvents. It may contain an inhibitor or a black pepper inhibitor, and if necessary, a color toning agent, a surfactant, an antifoaming agent, a water softener, a hardening agent, and JP-A-56-10
It may also contain the amino compounds described in No. 6244. The developing solution of the present invention contains a silver stain preventive agent.
.. The compounds described in No. 347 can be used. Patent application 1987-109.74 for a solubilizing agent added to the current imitation liquid
The compounds described in No. 3 can be used. .. In addition, as a pH41 buffer for use in developing solutions, JP-A-80-93.4
Compounds described in No. 33 or Japanese Patent Application No. 61-28708
Compounds described in this issue can be used. As the fixing agent, those having commonly used compositions can be used. As the fixing agent, in addition to thiosulfates and thiocyanates, organic sulfur compounds known to be effective as fixing agents can be used.
定着液には硬膜剤として水溶性アルミニウム(例えば硫
酸アルミニウム、明バンなど)を含んでもよい。ここで
水溶性アルミニウム塩の量としては通常0. 4〜2
,Og−All1である。さらに三価の鉄化合物を酸化
剤としてエチレンジアミン4酢酸との錯体として用いる
ことができる。The fixing solution may contain water-soluble aluminum (eg, aluminum sulfate, alum, etc.) as a hardening agent. Here, the amount of water-soluble aluminum salt is usually 0. 4-2
, Og-All1. Furthermore, a trivalent iron compound can be used as an oxidizing agent in the form of a complex with ethylenediaminetetraacetic acid.
現像処理温度は普通18℃から50℃の間で選ばれるが
より好ましくは25℃から43℃である。The development temperature is usually selected between 18°C and 50°C, more preferably between 25°C and 43°C.
(実施例)
次に、本発明について実施例にもとづいてより具体的に
説明する。実施例1に用いた現像液は下記に記載の処方
を用いた。(Examples) Next, the present invention will be described in more detail based on Examples. The developer used in Example 1 had the formulation described below.
(現像液処方)
ハイドロキノン 45、OgN−メチ
ルーp−アミノフエ
ノール1/2硫酸塩 0.8g水酸化ナトリ
ウム 18,Og水酸化カリウム
55.0g5−スルホサリチル酸 4
5.0gホウ酸 25,Og亜
硫酸カリウム 110.0gエチレンジア
ミン四酢酸二ナ
トリウム塩 1.0g臭化カリウ
ム 6.0g5−メチルベンゾトリ
アゾー
ル 0. 6gn
−ブチルジエタノールアミ
ン 15.
Og水を加えて 1l(pH=
1 1.6)
(実施例l)
以下の方法により、乳剤(A)CB)(C3CD)
(E) (F) (G) (H)を調製した。(Developer formulation) Hydroquinone 45, Og N-methyl-p-aminophenol 1/2 sulfate 0.8g Sodium hydroxide 18, Og Potassium hydroxide
55.0g 5-sulfosalicylic acid 4
5.0 g Boric acid 25, Og Potassium sulfite 110.0 g Ethylenediaminetetraacetic acid disodium salt 1.0 g Potassium bromide 6.0 g 5-Methylbenzotriazole 0. 6gn
-Butyldiethanolamine 15.
Add Og water to 1l (pH=
1 1.6) (Example 1) Emulsion (A) CB) (C3CD) was prepared by the following method.
(E) (F) (G) (H) were prepared.
50℃に保ったゼラチン水溶液中に硝酸銀水溶液と沃化
カリウムと臭化カリウムの水溶液を同時に60分間で加
え、その間pAgを7.5に保つことにより単分散の沃
臭化銀乳剤(平均粒子サイズ0.26μ、沃化銀含量2
モル%)を調製した。A monodisperse silver iodobromide emulsion (average grain size 0.26μ, silver iodide content 2
(mol%) was prepared.
この乳剤を常法に従って水洗し可溶性塩類を除去したの
ち、チオ硫酸ナトリウムを加えて化学増感を施した。さ
らに乳剤に沃化カリウムを添加して粒子表面をコンバー
ションすることにより粒子平均の沃化銀含有率/粒子表
面の沃化銀含有率=1/3の沃臭化銀乳剤を得た。これ
に防腐剤としてプロキセルを銀1モルあたり70■添加
した。This emulsion was washed with water in a conventional manner to remove soluble salts, and then chemical sensitization was performed by adding sodium thiosulfate. Further, potassium iodide was added to the emulsion to convert the grain surface, thereby obtaining a silver iodobromide emulsion having a grain average silver iodide content/grain surface silver iodide content=1/3. To this was added Proxel as a preservative at 70 μm per mole of silver.
この乳剤をAとした。This emulsion was designated as A.
50℃に保ったゼラチン水溶液中に硝酸銀水溶液と銀l
モル当たり6X10−’モルに相当するヘキサシアノ鉄
(n)酸カリウムを含む沃化カリウムと臭化カリウムの
水溶液を同時に60分間で添加し、その間pAgを7.
5に保つことにより、平均粒子サイズ0.26μ、沃化
銀含量2モル%の鉄含有率の均一である単分散の沃臭化
銀乳剤を調製した。Silver nitrate aqueous solution and silver l in gelatin aqueous solution kept at 50℃
An aqueous solution of potassium iodide and potassium bromide containing potassium hexacyanoferrate(n) corresponding to 6×10 − mol per mol was added simultaneously over 60 minutes, during which time the pAg increased to 7.
5, a monodisperse silver iodobromide emulsion having an average grain size of 0.26 μm, a silver iodide content of 2 mol %, and a uniform iron content was prepared.
この乳剤を乳剤Aと同様に水洗し、化学増感を施し、沃
化カリウムを添加し、防腐剤を添加した。This emulsion was washed with water in the same manner as Emulsion A, subjected to chemical sensitization, potassium iodide was added, and a preservative was added.
こうしてできた乳剤をBとした。The emulsion thus produced was designated as B.
50℃に保ったゼラチン水溶液中に硝酸銀水溶液と銀l
モルあたり5X10−’モルのへキサシアノ鉄(II)
酸カリウムを含む沃化カリウムと臭化カリウムの水溶液
を同時に30分間で添加し、その間pAgを7.5に保
つことにより平均粒子サイズ0.20μ、沃化銀含量2
モル%の単分散の沃臭化銀芯部粒子を調製した。その後
、硝酸銀水溶液と銀lモルあたり1×10−’モルのへ
キサシアノ鉄(n)酸カリウムを含むハロゲン塩水溶液
を同時に30分間で添加し、その間をpAg7.5に保
つことにより平均粒子サイズ0.26μ、沃化銀含量2
モル%、総鉄量4X10−’モル銀で鉄含有率について
二重構造の単分散の沃臭化銀を調製した。Silver nitrate aqueous solution and silver l in gelatin aqueous solution kept at 50℃
5X10-' moles of hexacyanoferrate(II) per mole
By simultaneously adding an aqueous solution of potassium iodide and potassium bromide containing acid potassium for 30 minutes and maintaining pAg at 7.5 during this period, an average grain size of 0.20μ and a silver iodide content of 2 were obtained.
Mol% monodispersed silver iodobromide core grains were prepared. Thereafter, a silver nitrate aqueous solution and a halogen salt aqueous solution containing potassium hexacyanoferrate (n) at a concentration of 1 x 10-' mol per mol of silver were simultaneously added for 30 minutes, and the pAg was maintained at 7.5 during this period, resulting in an average particle size of 0. .26μ, silver iodide content 2
A double-structured, monodisperse silver iodobromide was prepared for iron content in mole %, total iron content of 4×10 −′ mole silver.
この乳剤を乳剤Aと同様に水洗し、化学増感を施し沃化
カリウムと防腐剤を添加した。こうしてできた乳剤をC
とした。This emulsion was washed with water in the same manner as Emulsion A, subjected to chemical sensitization, and potassium iodide and a preservative were added. The emulsion thus made is
And so.
50℃に保ったゼラチン水溶液中に硝酸銀水溶液と銀1
モルあたりIXlO−’モルのへキサシアノ鉄(n)酸
カリウムを含む沃化カリウムと臭化カリウムの水溶液を
同時に30分間で添加し、その間pAgを7.5に保つ
ことにより平均粒子サイズ0.20μ、沃化銀含量2モ
ル%の単分散の沃臭化銀芯部粒子を調製した。その後硝
酸銀水溶液と銀lモルあたりsxto−’モルのへキサ
シアノ鉄(II)酸カリウムを含むハロゲン塩水溶液を
同時に30分間で添加し、その間pAgを7.5に保つ
ことにより平均粒子サイズ0.26μ、沃化銀含量2モ
ル%、総鉄量4XlO−7モル/モル銀で鉄含有率につ
いて二重構造の単分散の沃臭化銀を調製した。Silver nitrate aqueous solution and silver 1 in gelatin aqueous solution kept at 50℃
An aqueous solution of potassium iodide and potassium bromide containing IXlO-' moles of potassium hexacyanoferrate(n) per mole was added simultaneously over a period of 30 minutes, during which time the pAg was maintained at 7.5, resulting in an average particle size of 0.20μ. , monodispersed silver iodobromide core grains having a silver iodide content of 2 mol % were prepared. Thereafter, an aqueous silver nitrate solution and an aqueous halide solution containing potassium hexacyanoferrate (II) in an amount of sxto-' mol per mol of silver were simultaneously added for 30 minutes, during which time the pAg was maintained at 7.5, resulting in an average particle size of 0.26μ. A double-structured, monodisperse silver iodobromide was prepared in terms of iron content, with a silver iodide content of 2 mol% and a total iron content of 4XlO-7 mol/mole silver.
この乳剤を乳剤Aと同様に水洗し、化学増感を施し、沃
化カリウムと防腐剤を添加した。こうしてできた乳剤を
Dとした。This emulsion was washed with water in the same manner as Emulsion A, subjected to chemical sensitization, and potassium iodide and a preservative were added. The emulsion thus produced was designated as D.
50℃に保ったゼラチン水溶液中に硝酸銀水溶液と沃化
カリウムと臭化カリウムの水溶液を同時に30分間で添
加し、その間pAgを7.5に保つことにより平均粒子
サイズ0.20μ、沃化銀含量2モル%の鉄を含有しな
い単分散の沃臭化銀芯部粒子を調製した。その後硝酸銀
水溶液と銀1モルあたり6XlO−’モルのへキサシア
ノ鉄(II)酸カリウムを含むハロゲン塩水溶液を同時
に30分間で添加し、その間pAgを7.5に保つこと
により平均サイズ0。26μ、沃化銀含量2モル%、総
鉄量4XlO−’モル/モル銀で鉄含有率について二重
構造の単分散の沃臭化銀を調製した。A silver nitrate aqueous solution, potassium iodide and potassium bromide aqueous solutions were simultaneously added to an aqueous gelatin solution kept at 50°C for 30 minutes, and the pAg was maintained at 7.5 during that time, resulting in an average particle size of 0.20μ and a silver iodide content. Monodisperse silver iodobromide core grains containing 2 mol% iron were prepared. Thereafter, an aqueous silver nitrate solution and an aqueous halide solution containing potassium hexacyanoferrate(II) at 6XlO-' mol per mol of silver were simultaneously added for 30 minutes, during which the pAg was maintained at 7.5, so that the average size was 0.26μ. A monodisperse silver iodobromide with a double structure in terms of iron content was prepared with a silver iodide content of 2 mol % and a total iron content of 4XlO-' mol/mole silver.
この乳剤を乳剤Aと同様に水洗し、化学増感を施し沃化
カリウムと防腐剤を添加した。こうしてできた乳剤をE
とした。This emulsion was washed with water in the same manner as Emulsion A, subjected to chemical sensitization, and potassium iodide and a preservative were added. The emulsion thus made is
And so.
50°Cに保ったゼラチン水溶液中に硝酸銀水溶液と沃
化カリウムと臭化カリウムの水濱液を同時に60分間で
添加し、その間pAgを゛/.5に保った。そして添加
開始後6分に、粒子の金銀量lモル当たり6X10−’
モルに相当するヘキサシアノ鉄(II)酸カリウム水溶
液を添加し、平均粒子サイズ0.26μ、沃化銀含量2
モル%、鉄が粒子中心から、全粒子容積の10%の位置
に局在した沃臭化銀乳剤を調製した。An aqueous solution of silver nitrate and an aqueous solution of potassium iodide and potassium bromide were simultaneously added to an aqueous gelatin solution kept at 50°C for 60 minutes, during which time the pAg was adjusted to 1/2. I kept it at 5. Then, 6 minutes after the start of the addition, 6X10-' per mol of gold/silver particles
A molar amount of potassium hexacyanoferrate(II) aqueous solution was added, the average particle size was 0.26μ, and the silver iodide content was 2.
A silver iodobromide emulsion was prepared in which iron was localized at 10% of the total grain volume from the grain center.
この乳剤を乳剤Aと同様に水洗し、化学増感を施し、沃
化カリウムを添加し、防腐剤を添加した。This emulsion was washed with water in the same manner as Emulsion A, subjected to chemical sensitization, potassium iodide was added, and a preservative was added.
こうしてできた乳剤をFとした。The emulsion thus produced was designated as F.
完成乳剤の銀1モル当たり6X10−’モルに相当する
ヘキサシアノ鉄(II)酸カリウム水溶液を、硝酸銀水
溶液と沃化カリウムと臭化カリウムの水溶液添加開始後
、54分に添加する以外は乳剤Fと同様に調製し、水洗
、化学増感し、沃化カリウムと防腐剤を添加して、鉄が
粒子中心から全粒子容積の90%の位置に局在した沃臭
化銀乳剤をGとした。Emulsion F except that an aqueous solution of potassium hexacyanoferrate(II) corresponding to 6×10 −' mol per mol of silver in the finished emulsion was added 54 minutes after the start of addition of the aqueous solution of silver nitrate, potassium iodide, and potassium bromide. A silver iodobromide emulsion was prepared in the same manner, washed with water, chemically sensitized, potassium iodide and a preservative were added, and silver iodobromide emulsion in which iron was localized from the grain center to 90% of the total grain volume was designated as G.
50℃に保ったゼラチン水溶液中に硝酸銀水溶液と沃化
カリウムと臭化カリウムの水溶液を60分間で混合する
時、同時に第3の溶液としてヘキサシアノ鉄(II)カ
リウム水溶液を、添加速度を添加開始時、0から直線的
に増加させ、全鉄含有量が銀lモル当たり6X10−’
モルになるように60分間で添加する。こうして平均粒
子サイズ0.26μ、沃化銀含量2モル%、全鉄含有量
が銀1モル当たり6X10−5モルで鉄含有率が粒子中
心から粒子表面にむかって増加する沃臭化銀乳剤を調製
した。When mixing silver nitrate aqueous solution, potassium iodide and potassium bromide aqueous solution in a gelatin aqueous solution kept at 50℃ for 60 minutes, simultaneously add a potassium hexacyanoferrate (II) aqueous solution as a third solution, and adjust the addition rate at the start of addition. , increasing linearly from 0 until the total iron content is 6X10-' per mole of silver
Add in molar amounts over 60 minutes. Thus, a silver iodobromide emulsion with an average grain size of 0.26μ, a silver iodide content of 2 mol %, a total iron content of 6X10-5 mol per mol of silver, and an iron content increasing from the grain center to the grain surface was prepared. Prepared.
この乳剤を乳剤Aと同様に水洗、化学増感を施し、沃化
カリウム添加後、防腐剤と添加した。こうしてできた乳
剤をHとした。This emulsion was washed with water and chemically sensitized in the same manner as Emulsion A, and after addition of potassium iodide, a preservative was added. The emulsion thus produced was designated as H.
乳剤A−Hの鉄含有量、含有率についての構造、含有位
置と含有量を表1にまとめて示した。Table 1 summarizes the iron content of emulsions A to H, the structure of the iron content, the position of iron content, and the iron content.
*モル/銀モル
この乳剤に増感色素として銀1モルあたり3×10−4
モルの5,5′−ジクロロ−9−エチル−3,3′−ビ
ス(3−スルフオプロビル)オキサカルポシアニンを加
え、さらに安定剤として4一ヒドロキシ−6−メチル−
1. 3. 3a, 7−テトラザインデン、5
−メチルベンゾトリアゾール、下記化合物(al及び(
blをそれぞれ5■/ボ塗布される様添加した。*mol/silver mole 3 x 10-4 per mole of silver as sensitizing dye in this emulsion
mol of 5,5'-dichloro-9-ethyl-3,3'-bis(3-sulfoprobyl)oxacarpocyanine and 4-hydroxy-6-methyl- as a stabilizer.
1. 3. 3a, 7-tetrazaindene, 5
-Methylbenzotriazole, the following compounds (al and (
bl was added at a coating rate of 5 ml/bo.
(al
2CI”
ヒドラジン化合物として■−19またはI−7を表2の
ように添加した。さらに平均分子量600のポリエチレ
ングリコールを75■/ポになるように加え、ポリエチ
ルアクリレートの分散物を固形分で対ゼラチン比30*
t%、硬膜としてl, 3一ジビニルスルホニル−2
−プロパノールを加えポリエチレンテレフタレートフイ
ルム上に銀3.5g/mになる様に塗布した。(ゼラチ
ン2g/n{)この上に保護層としてゼラチン1.2g
/rd,粒子サイズ約3μの不定型なSiOzマット剤
40■/ポ、メタノールシリカ0.1g/m,ポリアク
リルアミドlOO■/rrr,ハイドロキノン200■
/耐とシリコーンオイル、防腐剤としてプロキセルとフ
エノキシエタノール及び塗布助剤として下記構造式で示
されるフッ素界面活性剤C.F.,SO.NCH.CO
OK
C.H,
とドデシルベンゼンスルフォン酸ナトリウムを含む層を
同時に塗布行ない表2のように試料1〜20を作製した
。(Al 2CI" hydrazine compound ■-19 or I-7 was added as shown in Table 2. Furthermore, polyethylene glycol with an average molecular weight of 600 was added at a rate of 75 ■/po, and the dispersion of polyethyl acrylate was and gelatin ratio 30*
t%, l, 3-divinylsulfonyl-2 as dura mater
-Propanol was added and coated onto a polyethylene terephthalate film at a silver concentration of 3.5 g/m. (2 g/n of gelatin) 1.2 g of gelatin as a protective layer on top of this
/rd, amorphous SiOz matting agent with particle size of about 3μ 40■/po, methanol silica 0.1g/m, polyacrylamide lOO■/rrr, hydroquinone 200■
/ silicone oil, Proxel and phenoxyethanol as preservatives, and a fluorosurfactant represented by the following structural formula as a coating aid C. F. , S.O. NCH. C.O.
OK C. Samples 1 to 20 were prepared as shown in Table 2 by simultaneously applying a layer containing H, and sodium dodecylbenzenesulfonate.
またバック層は次に示す処方にて塗布した。The back layer was coated using the following recipe.
ゼラチン 4g/耐マット剤
ポリメチルメタア
クリレート(粒子径3.0
〜4.0μ) 10■/dラテックス
ボリエチルアク
リレート
界面活性剤 p−ドデシルベ
ンベンスルフォン酸ナトリ
ウム
フッ素系界面活性剤
C.F,ISO.NCH2COOK
C 3 H 7
ゼラチン硬化剤
2 glrd
40■/d
5■/耐
染料 染料〔a〕、
染料[a)
染料〔b〕
染料〔c〕
110■/d
(b)及び〔c〕の混合物
50■/d
100■/ポ
50■/耐
染料〔a〕
SO.K
染料
[b)
SO3K
染料
〔c〕
SO.K
SO3K
SO.K
SO.K
またバック層塗布液には防腐剤としてプロキセルとフェ
ノキシエタノールを加えた。Gelatin 4g/anti-matting agent
Polymethyl methacrylate (particle size 3.0 to 4.0 μ) 10 μ/d latex Polyethyl acrylate surfactant Sodium p-dodecylbenbensulfonate Fluorine surfactant C. F.ISO. NCH2COOK C 3 H 7 Gelatin hardener 2 glrd 40■/d 5■/Dye-resistant Dye [a], Dye [a) Dye [b] Dye [c] 110■/d Mixture of (b) and [c] 50 ■/d 100■/Po50■/Dye resistance [a] SO. K dye [b] SO3K dye [c] SO. K SO3K SO. K SO. K Also, Proxel and phenoxyethanol were added as preservatives to the back layer coating solution.
なお、各実施例における評価は以下のテスト方法になっ
た。In addition, the following test method was used for evaluation in each example.
テスト方法
l.目伸ばし画質の評価
(1)原稿の作成
富士写真フイルム株式会社製モノクロスキャナーSCA
NART3 0及び専用感材SF−100を使って網点
よりなる人物の透過画像及び網パーセントを段階的に変
えたステップウエッジを作成した。この時スクリーン線
数は150線/インチで行なった。Test method l. Evaluation of image quality (1) Creation of manuscript Monochrome scanner SCA manufactured by Fuji Photo Film Co., Ltd.
A transparent image of a person consisting of halftone dots and a step wedge in which the halftone percentage was changed in stages were created using NART30 and special photosensitive material SF-100. At this time, the number of screen lines was 150 lines/inch.
(2)撮影
大日本スクリーン(株製製版カメラC−440に上記原
稿を目伸ばし倍率が等倍になる様にセットした後Xeラ
ンプを照射することにより評価サンプルに露光を与えた
。(2) Photography After setting the above-mentioned original on a Dainippon Screen (manufactured by Dainippon Screen Co., Ltd.) camera C-440 so that the magnification was 1:1, the evaluation sample was exposed to light by irradiating it with a Xe lamp.
この時原稿のステップウエッジの95%の部分が5%と
なる様にして露光を行なった。At this time, exposure was performed such that 95% of the step wedge of the original was exposed to 5%.
(3)評価
(2)の様に露光量を調節した小点側(ハイライト部)
の網点%を合わせたサンプルのシャードウ部の階調再現
性(網点のつぶれ難さ)の良いものから順に5段階評価
(5〜l)を行なった。(3) Small dot side (highlight area) with exposure adjusted as in evaluation (2)
A five-grade evaluation (5 to 1) was performed in descending order of the gradation reproducibility (difficulty of halftone dot collapse) in the shadow portion of the samples, which combined the halftone dot percentages.
2。コピードットの評価
(11 原稿の作成
富士写真フイルム株式会社製モノクロスキャナ−SCA
NART3 0及び専用ペーパーSP−1oowpを使
って網パーセント段階的に変えたステップウエッジを作
威した。露光時のスクリーン線数は150線lインチで
行なった。2. Copy dot evaluation (11 Manuscript creation Monochrome scanner-SCA manufactured by Fuji Photo Film Co., Ltd.
Using NART30 and special paper SP-1oowp, a step wedge in which the dot percentage was changed in stages was created. The number of screen lines during exposure was 150 lines/inch.
(2)撮影
大日本スクリーン■製製版カメラC−690(オートコ
ンパ二カ)に上記原稿及び試料を所定の位置にセットし
Xeランブを反射原稿に照射し撮影した。(2) Photography The above manuscript and sample were set in predetermined positions in a Dainippon Screen ■ plate-making camera C-690 (Auto Companica), and a Xe lamp was irradiated onto the reflective manuscript and photographed.
この時露光時間は、原稿上でステップウエッジの80%
の部分がサンプル上で10%となる様に調整した。At this time, the exposure time is 80% of the step wedge on the original.
It was adjusted so that the portion was 10% on the sample.
(3)評価
(2)に記載の如く露光時間を調節して小点側の網パー
セントがlO%のサンプルのシャドウ部の階調再現性(
網点のつずれ難さ)の良いものを5、悪いものを1とし
て5段階の相対評価を行った。(3) Tone reproducibility of the shadow part of the sample with halftone percentage on the small dot side by adjusting the exposure time as described in (2) (2)
Relative evaluation was performed on a five-level scale, with 5 being good and 1 being bad in terms of halftone dot shift difficulty.
得られた試料をキセノン光源により露光を行ない、現像
液、定着液として富士写真フイルム(掬製GR−DL
GR−F 1および自動現像機FG−660Fを用いて
、34℃30秒現像を行ない目伸し性能およびコピード
ット性能を評価した。The obtained sample was exposed to light using a xenon light source, and Fuji Photo Film (Kiki GR-DL) was used as a developer and fixer.
Development was performed at 34° C. for 30 seconds using GR-F 1 and an automatic processor FG-660F, and the eye stretching performance and copy dot performance were evaluated.
ここで感度は34°C30秒現像における濃度l.5を
与える露光量の逆数の相対値で試料lの値を100とし
た。Here, the sensitivity is the density l. The value of sample 1 was set to 100 based on the relative value of the reciprocal of the exposure amount giving 5.
Dmaxは、実技のDmaxに相当する濃度で示した。Dmax is expressed as a concentration equivalent to Dmax in practical skill.
(特性曲線上で、濃度0.1の感度点に対してj!og
Eで+0.5の露光量における濃度)結果を表2に示し
た。表2より明らかなように本発明の試料は比較試料に
較べ、感度、γ、最高濃度Dmaxが高く、黒ボツも良
好で、かつ画質も良化する。(On the characteristic curve, j!og for the sensitivity point of density 0.1
The results are shown in Table 2. As is clear from Table 2, the samples of the present invention have higher sensitivity, γ, and maximum density Dmax, have better black spots, and have better image quality than the comparative samples.
(実施例2)
実施例1で用いた乳剤DSE,G,Hに本発明の一般式
(II)の化合物を表3の様に添加し、さらに実施例l
と同様の化合物を添加し、塗布を行ない試料2l〜34
を作或した。これらの試料を実施例lと同様の評価を行
なった。結果を表3に示す。表より明らかな様に本発明
の一般式(II)の化合物の存在で、画質がさらに良化
する。(Example 2) The compound of general formula (II) of the present invention was added to the emulsions DSE, G, H used in Example 1 as shown in Table 3, and further
Samples 2l to 34 were prepared by adding the same compound as above and coating.
was created. These samples were evaluated in the same manner as in Example 1. The results are shown in Table 3. As is clear from the table, the presence of the compound of general formula (II) of the present invention further improves the image quality.
(実施例3)
一般式(n)の化合物として実施例2で用いた化合物の
かわりに、II−1を銀1モルあたり5×10−5モル
または■−27を銀1モルあたり5×lO−5モルまた
はII−25を銀1モルあたり5×IO−5モル用いた
以外は、実施例2と全く同様に試料を作成し、同様の方
法で評価を行なったところ、実施例2と同様に本発明の
構成の試料が良好な画質を示した。(Example 3) Instead of the compound used in Example 2 as the compound of general formula (n), II-1 was used at 5 x 10-5 mol per mol of silver or ■-27 was added at 5 x 1O per mol of silver. Samples were prepared in exactly the same manner as in Example 2, except that -5 mol or II-25 was used at 5 x IO-5 mol per mol of silver, and evaluation was performed in the same manner as in Example 2. Samples with the configuration of the present invention showed good image quality.
Claims (2)
を有するハロゲン化銀写真感光材料において、該乳剤層
が銀1モルあたり少なくとも1×10^−^7モルの鉄
塩を含有するハロゲン化銀乳剤からなり、該ハロゲン化
銀乳剤のハロゲン化銀粒子が該粒子表面から全粒子容積
の50%に相当する部分に全粒子中の鉄含量の60%以
上の鉄を含んでいる粒子でありかつ該乳剤層又はその他
の親水性コロイド層中に下記一般式( I )で表わされ
るヒドラジン誘導体を含むことを特徴とするハロゲン化
銀写真感光材料。 一般式( I ) ▲数式、化学式、表等があります▼ 式中、R_1は脂肪族基または芳香族基またはヘテロ環
基を表わし、R_2は水素原子、アルキル基、アリール
基、アルコキシ基、アリールオキシ基、アミノ基、カル
バモイル基又はオキシカルボニル基を表わし、G_1は
カルボニル基、スルホニル基、スルホキシ基、▲数式、
化学式、表等があります▼−基、▲数式、化学式、表等
があります▼−基、チオカルボニル基、又はイミノメチ
レン基を表わし、A_1、A_2はともに水素原子ある
いは一方が水素原子で他方が置換もしくは無置換のアル
キルスルホニル基、又は置換もしくは無置換のアリール
スルホニル基、又は置換もしくは無置換のアシル基を表
わす。(1) In a silver halide photographic material having at least one silver halide emulsion layer on a support, the emulsion layer contains a halogen containing at least 1 x 10^-^7 moles of iron salt per mole of silver. A grain consisting of a silver halide emulsion, in which the silver halide grains of the silver halide emulsion contain iron in an amount corresponding to 50% of the total grain volume from the grain surface in an amount of 60% or more of the iron content in the whole grain. 1. A silver halide photographic light-sensitive material comprising a hydrazine derivative represented by the following general formula (I) in the emulsion layer or other hydrophilic colloid layer. General formula (I) ▲There are numerical formulas, chemical formulas, tables, etc.▼ In the formula, R_1 represents an aliphatic group, aromatic group, or heterocyclic group, and R_2 is a hydrogen atom, an alkyl group, an aryl group, an alkoxy group, an aryloxy group, amino group, carbamoyl group or oxycarbonyl group, G_1 is carbonyl group, sulfonyl group, sulfoxy group, ▲ formula,
Chemical formulas, tables, etc. are available ▼ - group, ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ - group, thiocarbonyl group, or iminomethylene group, A_1 and A_2 are both hydrogen atoms, or one is a hydrogen atom and the other is substituted or represents an unsubstituted alkylsulfonyl group, a substituted or unsubstituted arylsulfonyl group, or a substituted or unsubstituted acyl group.
れることにより現像抑制剤を放出するレドックス化合物
を含有することを特徴とする請求項1記載のネガ型ハロ
ゲン化銀写真感光材料。(2) The negative-working silver halide photographic material according to claim 1, wherein the emulsion layer or other hydrophilic colloid layer contains a redox compound that releases a development inhibitor upon oxidation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1307362A JP2648973B2 (en) | 1989-11-27 | 1989-11-27 | Silver halide photographic material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1307362A JP2648973B2 (en) | 1989-11-27 | 1989-11-27 | Silver halide photographic material |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03167545A true JPH03167545A (en) | 1991-07-19 |
JP2648973B2 JP2648973B2 (en) | 1997-09-03 |
Family
ID=17968175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1307362A Expired - Fee Related JP2648973B2 (en) | 1989-11-27 | 1989-11-27 | Silver halide photographic material |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2648973B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1700710A1 (en) | 2005-03-08 | 2006-09-13 | Konica Minolta Medical & Graphic, Inc. | Printing method, sheet material and mounting method of printing plate |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4835373A (en) * | 1971-08-30 | 1973-05-24 | ||
JPS613136A (en) * | 1984-06-15 | 1986-01-09 | Fuji Photo Film Co Ltd | Preparation of silver halide emulsion and silver halide emulsion |
JPS61213847A (en) * | 1985-03-19 | 1986-09-22 | Fuji Photo Film Co Ltd | Silver halide photosensitive material |
JPS63296032A (en) * | 1987-05-28 | 1988-12-02 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
JPS6472140A (en) * | 1987-09-12 | 1989-03-17 | Konishiroku Photo Ind | Silver halide photographic sensitive material |
JPH01121844A (en) * | 1987-11-06 | 1989-05-15 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
JPH01183647A (en) * | 1988-01-18 | 1989-07-21 | Fuji Photo Film Co Ltd | Silver halide sensitive material |
-
1989
- 1989-11-27 JP JP1307362A patent/JP2648973B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4835373A (en) * | 1971-08-30 | 1973-05-24 | ||
JPS613136A (en) * | 1984-06-15 | 1986-01-09 | Fuji Photo Film Co Ltd | Preparation of silver halide emulsion and silver halide emulsion |
JPS61213847A (en) * | 1985-03-19 | 1986-09-22 | Fuji Photo Film Co Ltd | Silver halide photosensitive material |
JPS63296032A (en) * | 1987-05-28 | 1988-12-02 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
JPS6472140A (en) * | 1987-09-12 | 1989-03-17 | Konishiroku Photo Ind | Silver halide photographic sensitive material |
JPH01121844A (en) * | 1987-11-06 | 1989-05-15 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
JPH01183647A (en) * | 1988-01-18 | 1989-07-21 | Fuji Photo Film Co Ltd | Silver halide sensitive material |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1700710A1 (en) | 2005-03-08 | 2006-09-13 | Konica Minolta Medical & Graphic, Inc. | Printing method, sheet material and mounting method of printing plate |
Also Published As
Publication number | Publication date |
---|---|
JP2648973B2 (en) | 1997-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU593636B2 (en) | Silver halide photographic material and image-forming method using the same | |
JPS61122642A (en) | Silver halide photosensitive material | |
JPS6255643A (en) | Silver halide photographic sensitive material and super-contrasty negative image forming method using it | |
JP2813747B2 (en) | Image forming method | |
JP2663042B2 (en) | Silver halide photographic material | |
JP2709647B2 (en) | Image forming method | |
JPH0816777B2 (en) | Image forming method | |
JP2694364B2 (en) | Image forming method using silver halide photographic light-sensitive material | |
JPH03167545A (en) | Silver halide photographic sensitive material | |
JP2627195B2 (en) | Silver halide photographic material | |
JP2794492B2 (en) | Silver halide photographic material | |
JP2709753B2 (en) | Silver halide photographic material | |
JP2887367B2 (en) | Image forming method | |
JP2717462B2 (en) | Silver halide photographic material | |
JP2604243B2 (en) | Silver halide photographic material | |
JP2714706B2 (en) | Silver halide photographic material | |
JP2709764B2 (en) | Silver halide photographic material | |
JP2694570B2 (en) | Silver halide photographic material | |
JP2709654B2 (en) | Silver halide photographic material | |
JPH03154045A (en) | Silver halide photographic sensitive material | |
JPH03290644A (en) | Silver halide photographic sensitive material | |
JPH05313276A (en) | Silver halide photographic sensitive material | |
JPH04174424A (en) | Silver halide photosensitive material for photography | |
JPH04317054A (en) | Method for processing black-and-white silver halide photographic sensitive material | |
JPH03291646A (en) | Processing method for silver halide photographic sensitive material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees | ||
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |